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Abstract: The focus of this review is on the physical and magnetic properties that are related to the
efficiency of monometallic magnetic nanoparticles used in biomedical applications, such as magnetic
resonance imaging (MRI) or magnetic nanoparticle hyperthermia, and how to model these by
theoretical methods, where the discussion is based on the example of cobalt nanoparticles. Different
simulation systems (cluster, extended slab, and nanoparticle models) are critically appraised for their
efficacy in the determination of reactivity, magnetic behaviour, and ligand-induced modifications of
relevant properties. Simulations of the effects of nanoscale alloying with other metallic phases are
also briefly reviewed.
Keywords: nanoparticles; density functional theory; magnetic hyperthermia; magnetic anisotropy
1. History of Use and Study of Metal Nanoparticles in Biomedicine
Metal nanoparticles (MNPs) have been attracting researchers’ attention for over a
century, owing to the diversity in their properties and the unique phenomena that only
exist at the nanoscale and have unlocked many new pathways to implement metals as
technology materials. However, MNPs have been used, albeit unknowingly, long before
modern ages. They were an integral part in the cosmetics of the ancient Egyptians, whereas
the Romans were famous for their workmanship of stained glass which evolved from the
absorption of light through gold and silver MNPs—the most renowned example being the
Lycurgus cup. The trend of dyed glass and metal-resembling glazes on ceramic pottery
continued deep into the Middle Ages before the origin of the colouring effects was linked
to the presence of optically active colloidal nanosized metallic particles in 1857 by Michael
Faraday. Today, efforts to unravel new tuning strategies leading to desired properties of
MNPs continue to grow, and utilisation of such nanotechnology has moved a long way
from stained glass, reaching an extensive range of confirmed and potential applications
in catalysis [1–4], electronics [5–7], optics [8–11], information storage [12–14], and finally,
medicine [15–19].
MNPs can exist as common single element structures, constituting alkali/alkaline,
transition, or noble metals, or they can be composites of two or more different metals,
known as nanoalloys. Their physical and chemical characteristics are determined not only
by the chemical composition as in the respective bulk materials, but also by their size
and morphology. Therefore, tailoring of the MNP properties depends on the strict control
of each of these parameters. Only recently have advances in experimental equipment
and methods led to the synthesis of MNPs of a uniform size distribution with directed
morphology control of particles synthesised in solution, giving rise to the development
of numerous production techniques. Today, procedures to generate MNPs with extensive
control over their size and shape are well established, even to the point of reaching atomic-
level precision in cluster and MNP synthesis, isolation, and deposition on a support [20,21].
Materials 2021, 14, 3611. https://doi.org/10.3390/ma14133611 https://www.mdpi.com/journal/materials
Materials 2021, 14, 3611 2 of 50
Such progress has enabled the correlation between the MNP properties and size and shape
effects, with multiple examples cited in the recent literature [22–28]. Nonetheless, MNPs are
principally neither isolated nor clean, rather frequently stabilised by solvent or surfactant
molecules or in form of particle aggregates, the presence of which makes the structural
determination cumbersome. Consequently, experimental characterisation techniques still
face significant challenges in assigning the influence of structural parameters on certain
properties over the size distribution of the synthesised MNPs [29], and computational sim-
ulations have been shown to significantly contribute to the unravelling of size, morphology,
and environmental effects on properties of individual MNPs [30–34].
In recent years, the emerging potential of MNPs with specific magnetic properties
(called magnetic metal nanoparticles, mNPs, in the remaining text) has brought further
advances in biomedicine. Their response to an externally applied magnetic field, in com-
bination with easy conjugation of the metallic surfaces with various functional groups
present in biomolecules, antibodies, and drugs of interest, has opened up a completely
new range of biomedical applications, where magnetically induced preconcentration, iden-
tification, and separation are merged with targeted medical analytes in a single agent at
the nanometre scale. This approach has allowed the development of drug delivery with
reduced distribution of medical substances in untargeted tissues and improved contrasts
in body scans through magnetic resonance imaging, whereas hyperthermia therapies have
progressed from treatments increasing whole-body temperature to treatments with com-
pletely localised magnetically induced heat generation, as described in the following text.
Initially, the focus was on the use of magnetic nanoparticles of biocompatible metallic
oxides, mainly magnetite/maghemite, but upon the failed efforts to sufficiently improve
their magnetic moments to fulfil the requirements of the therapies, naturally magnetic
metallic counterparts, mNPs, have started to generate an appreciable amount of interest.
Many of such mNP agents are already approved for clinical use, but the search for those
with superior response and higher efficiencies at safer external field strengths continues,
including less obvious material choices, such as Co mNPs, as promising candidates.
A comprehensive, although not by any means complete, summary of magnetic core
NPs with protective coatings designed for biomedical purposes can be found in Table 1.
There are many reviews on the role of iron oxide magnetic nanoparticles in biomedicine,
with details behind the exhaustive efforts to adjust their properties for specific applica-
tions [35–41]. However, the topics of the current review are metal nanoparticles, the
interplay between their physical and magnetic properties as they relate to the performance
in biomedical applications, and how to approach and predict this dependence from a
computational modelling perspective, focusing on the example of cobalt mNPs.
1.1. Biomedical Applications of mNPs
1.1.1. MRI
Magnetic resonance imaging (MRI) is a powerful, noninvasive, and sensitive tomo-
graphic visualisation technique widely used in biomedicine to obtain high-resolution scans
of body cross-sections. An MRI image originates from the measurement of nuclear mag-
netic resonance (NRM) signals that are collected as responses of abundant water protons
present in biological tissues to the applied magnetic field [42–44]. In rare cases, signals
are detected from other nuclei, such as C13, P31, or Na25. A strong static magnetic field
is first applied to align the magnetic moments of proton nuclei, which are then deflected
in the transversal plane upon the application of a short radiofrequency pulse. Magnetic
moments spontaneously return to the original longitudinal direction of the magnetic field,
and the time necessary for the complete realignment is called relaxation time. One can
distinguish between the T1 relaxation time corresponding to the longitudinal recovery
and the T2 relaxation time of the transversal decay. Both are sources of tissue contrasts in
MRI scans, which depend on the net magnetic effect of a large number of nuclei within a
specific voxel of tissue. Contrasting black and white areas of the MRI image correspond
to the disproportionate T1 and T2 proton relaxation times of various biological tissues
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as a consequence of differences in their compositions and proton density, resulting in
distanced signal intensities. However, the limited virtue of these differences can sometimes
cause low sensitivity of the technique, resulting in inadequate image contrasts for certain
clinical objectives.
Table 1. Classification of magnetic NPs based on the core and coating materials and their respective applications.
Magnetic Core Reported Coating Materials Application Ref
Metal
Fe
polymers MRI, drug delivery [45–47]
iron oxide MRI, hyperthermia [48]
Au drug delivery, photothermal therapy [49]
Co
organic acids drug delivery, hyperthermia [50]
polymers MRI [51]
Au MRI, gene transport, hyperthermia [52–55]
FeCo
graphite MRI, optical imaging [56,57]
CoFe2O4 hyperthermia [58]
Au MRI, medical labelling [59]
FePt
Au MRI, photothermal therapy [60,61]
organic acids/thiols biosensors, MRI, CT [62–66]
SiW11O39 hyperthermia [67]
polymer + SiO2 drug delivery [68]
FeNi polymers hyperthermia [69]
FeNiCo propylene glycol hyperthermia [70]
Oxide
Fe3O4
SiO2, TiO2 MRI, photokilling agents [71–73]
dextran, DMSA MRI [74]
Au, Ag MRI, immunosensor, photothermal therapy [75–78]
Fe2O3
SiO2 MRI, biolabelling [79,80]
polymers MRI, biolabelling, drug delivery, optical imaging [81,82]
MnFe2O4 polymers and organic acids MRI [83,84]
CoFe2O4
polymers and organic acids MRI, drug delivery, hyperthermia [84–86]
Au + PNA oligomers biosensors, genomics [87]
NiFe2O4




polymers and organic acids MRI [81]
SiO2 biolabelling [93]
Because the relaxation process involves an interaction between the protons and their
immediate molecular environment, it is possible to administer MRI contrast agents that
alter the magnetic characteristics within specific tissues or anatomical regions and improve
the image contrast [94–96]. Those contrast agents are individual molecules or particles
with unpaired electrons (paramagnetic metal–ligand complexes or magnetic particles) that
produce inhomogeneities in the magnetic field causing a rapid dephasing of nearby protons
and change in their relaxation rate. Contrast agents can be divided into those that shorten
the longitudinal recovery time, resulting in a brighter image, i.e., positive or T1 agents,
and those that shorten the transversal decay time, i.e., negative or T2 agents. The principle
of MRI and the use of contrast agents is shown in Figure 1. Contrast agents are used in
40–50% of all MRI examinations.
The first paramagnetic complex approved in 1987 for use in cancer patients to detect
brain tumours was gadolinium(III) diethylenetetraamine pentaacetic acid (GdDTPA) [97].
With rising concerns over the safety of Gd complexes, which have been found to remain
in the body after multiple MRI scans, the World Health Organization (WHO) issued
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a series of restrictions on their use as contrast agents in 2009 [98,99]. This stimulated
intense interest in creating responsive superparamagnetic T2 agents that show higher
biocompatibility and safety. Currently, the majority of T2 contrast agents are iron oxide
based superparamagnetic NPs (SPIONs) coated with dextran, silicates, or other polymers
with variable T2 relaxivities [100–102]. Recent studies investigating the transformation
of SPIONs into T1 contrast agents have generated some promising results, but effective
contrast enhancement is still lacking, due to the unknown relaxation mechanisms, and
nanoparticulate T1 contrast agents have yet to be approved for clinical use [103–106].
This flexibility makes iron oxide NPs attractive for detecting specific biological tissues,
but their relatively large sizes still impede cell penetration and delivery, while lower
values of their magnetic moments require increased clinical uptake to compensate for the
poor contrast obtained when compared to gadolinium-based agents. Low efficacy has
led to a discontinuation of a number of prominent iron oxide contrast agents in recent
years [107–109], and currently, only ultrasmall particles (USPIONs) remain in clinical use.
Superparamagnetic iron–platinum mNPs have been reported to have significantly better T2
relaxivities than SPIONs and USPIONs [110], while iron mNPs offer an order of magnitude
greater susceptibility at room temperature [111,112]. As a result, these are currently agents
of significant interest and the topic of much investigation, together with cobalt mNPs,
whose very high saturation magnetisation (1422 emu/cm3 for cobalt compared to 395
emu/cm3 for iron oxide at room temperature) offers a larger effect on proton relaxation,
promising improved MRI contrast whilst allowing smaller particle cores to be used without
compromising sensitivity [51,55].
Figure 1. Schematic representation of the principle behind the MRI contrast agents.
1.1.2. Magnetic Hyperthermia
Hyperthermia, in terms of medical treatments, is defined as a moderate increase in
temperature (to 40–45 ◦C) sufficient to cause death of tumorous cells whose vulnerability to-
wards heat originates from the poor blood flow and insufficient oxygenation in the affected
region [113–115]. Initially, hyperthermia treatments used water baths; later, conventional
therapies proceeded to noncontact external devices for transfer of thermal energy either by
irradiation or by electromagnetic waves (microwave, radiofrequency, ultrasound, or laser
sources). However, the realisation of the full clinical potential of hyperthermia treatments
was limited due to the inability of heat sources to target tumorous cells efficiently and
locally. As the effectiveness reduces steeply with the distance from the source, targeted
regions were not receiving enough thermal energy, while maximal temperature gradient
was obtained on the body’s surface. However, the biggest shortcoming was the dissipation
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of energy that was causing serious damage in the healthy tissue situated near the main path
of the radiation beam. Altogether, conventional hyperthermia showed no discrimination
between targeted tissue and surrounding environment. The growing usage of magnetic
nanosystems initiated an efficient solution, where the problem of an external source could
now be circumvented by the intravenous administration of magnetic NPs, followed by
the use of an alternating magnetic field that results in the localised transformation of
electromagnetic energy into heat by means of NP relaxation mechanisms. This targeted
approach allows local heating of tumorous cells with minimal impact on the surrounding
tissues. The principle of magnetic nanoparticle hyperthermia is presented in Figure 2.
Figure 2. Schematic representation of the principle of magnetic nanoparticle hyperthermia for
liver cancer.
The magnetic hyperthermia nanoagents implemented thus far are mostly magnetite
and maghemite NPs [116–120]. However, despite the promising results of preclinical trials,
there are many ongoing challenges in making magnetic nanoparticle hyperthermia a uni-
versal cancer treatment, including the establishment of optimal limits on the strength and
frequency of the applied magnetic field, their correlation with the duration of the treatment,
and determination of sufficient NP concentrations [121–125]. As the magnetic gradient
decreases with the distance from the source of the applied magnetic field, restrictions on
the human-safe magnetic field strengths impose challenges in obtaining the necessary
gradients to control the residence time of NPs in the desired area. Additionally, estimates
of the magnetic field strengths and gradients based on the hydrodynamic conditions of
vascular vessels have shown that the highest effectiveness of magnetic targeting is in
the regions of slower blood flow, which are usually near the surface [126–128]. Research
on the internal magnets implanted in the vicinity of the targeted tissue using minimally
invasive surgery is ongoing, and several studies have succeeded in simulating the inter-
action between an implant and a magnetic agent [129–132]. In terms of the amount of
NPs that can be incorporated in a single living cell, the admissible intake is of the order
of a few picograms [133–135]. This limit makes it essential that the nanoparticular agents
have high magnetic moments, because a relatively small number of particles (between 103
and 104) has to be capable of increasing the intracellular temperature by several degrees,
where mNPs have an important advantage over the relatively weak magnetic moments
of iron oxides. There are several excellent reviews in the literature on the principles and
requirements of magnetic nanoparticle hyperthermia [136–140].
Nanoparticle hyperthermia can also be combined with other therapies to form multi-
modality treatments and provide a superior therapy outcome [141]. One possibility is to
merge it with chemotherapy, where heat can enhance the cytotoxicity of chemotherapeutic
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drugs or assist the drug uptake by increasing the local blood supply and tissue oxygena-
tion [142–144]. Besides the synergy with chemotherapy, the combination of unique mag-
netic and optical properties in a single NP system leads to multimodal photothermal and
thermal photodynamic treatments [145–149]. In nano-photodynamic therapy, mNPs act as
photosensitiser carriers that under the irradiation with visible (VIS) and/or near-infrared
(NIR) light generate reactive oxygen species (ROS) able to cause tumour degradation.
Multiple studies on glioblastoma have shown that the combination of nanoparticulate
hyperthermia and photodynamic treatments is quite effective to treat this type of can-
cer [150]. In nano-photothermal therapy, a nanosized photothermal agent is stimulated by
both specific band light and vibrational energy/heat release to selectively target abnormal
tissues. A number of magnetic nanomaterials with appropriate optical characteristics have
been developed by bringing together a magnetic core and, for example, gold coatings,
carbon nanotubes, or graphene, all of which show strong optical absorbance in the NIR
optical transparency window of biological tissues. The major advantage of the combined
electron–phonon and magnetic relaxations is the significant reduction in the laser power
density required for efficient therapies [151,152]. Recently, a pilot study on the initial evalu-
ation of nano-photothermal agents based on gold nanoshells in the treatment of prostate
cancer confirmed the clinical safety of this combined therapy [153].
1.1.3. Targeted Drug Delivery
One of the most rapidly developing areas of modern pharmacology is targeted drug
delivery, with the aim to reduce the drug intake per dose and prevent exposure of healthy
tissue to chemically active analytes. In 1906, Paul Ehrlich introduced the term magic bullet,
describing the drug capable of locating the causative agent of the disease and providing the
adequate treatment without further distribution to unaffected areas [154]. Several decades
later, the first drug delivery systems were developed, containing active medical substances
attached to the surface of a carrier or encapsulated within the carrier which possesses
specific cell affinity contained within molecular vectors and would disintegrate and release
the capsulated drug upon contact with diseased cells [155–157]. Organic nanosystems
(liposomes, micelles, polymer NPs) [158–160] together with carbon nanotubes and fullerene
NPs [161–163] are the most often employed drug carriers, while different hormones, en-
zymes, peptides, antibodies, and viruses often serve as molecular vectors [164–167]. Thus
far, the available carriers and capsules for targeted drug delivery have each shown several
disadvantages, from limited chemical and mechanical stability of organic NPs, over the
questionable toxicity of carbon-based systems, to the general susceptibility to microbio-
logical attack, lack of control over the carrier movement and the rate of drug release, and,
finally, high cost [168–171]. Hence, the search for an optimal carrier has shifted direction
towards utilising the magnetically induced movement of magnetic nanosystems. Their
main advantages are simple visualisation (based on the principles of MRI), easy guidance
and retention in the desired area by externally applied magnetic field, and controllable
drug detachment triggered by heat released in the variable magnetic field (based on the
principles of magnetic hyperthermia). In addition, it is possible to engineer magnetic NPs
to either avoid or interact with the immune system in specific ways [172,173].
In common with the previous two applications, most attention has been devoted to
iron oxide NPs [174–176]. However, limitations of magnetic drug delivery have promoted
the search for materials of higher magnetic moments [177] due to the decrease in the
magnetic gradients connected to the distance from the source as well as to the fluid
hydrodynamics correlating with the depth of the affected tissue—i.e., the same drawbacks
as in hyperthermia treatments. So far, a combination of relatively strong magnetic fields
with SPION drug carriers has been shown to reach an effective depth of 10–15 cm in the
body [178]. Other restrictions relate to the acceptable size of the NPs; first, they have to
be below the critical size for optimal magnetic properties, which is a prerequisite to avoid
magnetic memory and agglomeration once the magnetic field is removed, and second, they
have to be small enough such that after the attachment of drug molecules on their surface
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they can still effectively pass through narrow barriers [179,180]. The small size implies a
reduced magnetic response and hence requires materials of high magnetisation, such as
mNPs, rather than metal oxides. Recently, 5–25 nm diameter cobalt–gold mNPs with a core–
shell structure and tailorable morphology were synthesised for the purpose of obtaining
high-magnetisation drug carriers [181]. The major advantage of the implementation of
cobalt within the mNP core is that it has a magnetic moment nearly twice that of iron oxides.
2. Features of mNPs
2.1. Electronic and Magnetic Properties of mNPs
The proper functionality of mNPs for specific applications depends on their mag-
netic properties, as well as their biophysical behaviour under physiological conditions.
While the latter is most efficiently captured by in vivo experiments, insight into the depen-
dence of magnetic properties of nanometre-scale particles on their size, composition, and
morphology can be reliably obtained by computer modelling techniques.
Magnetic properties of mNPs can be classified as intrinsic or extrinsic. The former
are more important since they are derived from the interactions on an atomic length
scale and highly depend on chemical composition and grain size, shape, and crystal
microstructure. Additionally, they are much more affected by surface effects and therefore
give rise to specific manifestations, such as superparamagnetism, that can only be found
at the nanoscale level. These properties include magnetic saturation, anisotropy, and the
Curie temperature.
Intrinsically, classification of mNPs based on the ordering of their magnetic moments
corresponds to the classes of bulk metallic materials, and hence there are paramagnetic
and ferromagnetic mNPs. Those that are paramagnetic exhibit no collective magnetic
interactions and they are not magnetically ordered; however, in the presence of a magnetic
field, there is a partial alignment of the atomic magnetic moments in the direction of the
field, resulting in a net positive magnetisation. mNPs belonging to the ferromagnetic class
exhibit long-range magnetic order below a certain critical temperature, resulting in large
net magnetisation even in the absence of the magnetic field. If the diameter of the mNP
is larger than the critical value, DC, coupling interactions cause mutual spin alignment of
adjacent atoms over large volume regions called magnetic domains. Domains are separated
by domain walls, in which the direction of magnetisation of dipoles rotates smoothly from
the direction in one domain towards the direction in the next. Once the diameter falls under
the critical value (typically between 3 and 50 nm), mNPs can no longer accommodate a
wall and each of them becomes a single domain. Additionally, since each domain is also
a separate particle, there can be no interactions or ordering of domains within a sample,
and particles do not retain any net magnetisation once the external field has been removed.
This phenomenon is known as superparamagnetism. Superparamagnetic mNPs are, as
the name suggests, much alike paramagnetic mNPs apart from the fact that this property
arises from ferromagnetism. Their normal ferromagnetic movements combined with very
short relaxation times enable the spins to randomly flip direction under the influence of
temperature or to rapidly follow directional changes in the applied field. The temperature
above which the thermal energy will be sufficient to suppress ferromagnetic behaviour is
called the blocking temperature, TB. Below TB, the magnetisation is relatively stable and
shows ferromagnetic behaviour, while for T > TB, the spins are as free as in a paramagnetic
system and particles behave superparamagnetically. Blocking temperatures for most mNPs
are below 100 K [182–185], and their behaviour is therefore paramagnetic, as for most
temperatures they are only magnetised in the presence of the external field, but their
magnetisation values are in the range of ferromagnetic substances. Moreover, the strength
of the external field needed to reach the saturation point of superparamagnetic mNPs is
comparable to that of ferromagnetic mNPs.
The highest magnetisation that mNPs can obtain when exposed to a sufficiently large
magnetic field is called the saturation magnetisation, MS. It is the maximum value of
the material’s permeability curve, where permeability, µ, is the measure of magnetisation
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that a material obtains in response to an applied magnetic field (total magnetisation of
material per volume). It is often correlated with the ratio of magnetisation to the intensity
of an applied magnetic field H, which is known as the magnetic susceptibility, χ, and
describes whether a material is attracted into or repelled out of a magnetic field. The
magnitude of saturation is a function of temperature; once it is reached, no further increase
in magnetisation can occur even by increasing the strength of the applied field. The unique
temperature limit at which ferromagnetic mNPs can maintain permanent magnetisation is
the Curie temperature, TC. Notably, when the mNP size is reduced from multidomain to a
single domain, the magnitude of MS decreases due to the increment in the spin disorder
effect at the surface; thus, the MS value is also directly proportional to the size of mNPs.
In almost all cases, magnetic materials contain some type of anisotropy that affects
their magnetic behaviour. The most common types of anisotropy are (a) magneto-crystalline
anisotropy (MCA), (b) surface anisotropy, (c) shape anisotropy, (d) exchange anisotropy,
and (e) induced anisotropy (by stress, for example), where MCA and shape anisotropy
are the most important in mNPs. Magneto-crystalline anisotropy is the tendency of the
magnetisation to align along a specific spatial direction rather than randomly fluctuate
over time. It arises from spin–orbit interactions and energetically favours alignment of
the magnetic moments along the so-called easy axis. Factors affecting the MCA are the
type of material, temperature, and impurities, whereas it does not depend on the shape
and size of the mNP. Morphology effects are included in the shape anisotropy. Stress
anisotropy implies that magnetisation might change with stress, for example when the
surfaces are modified through ligand adsorption, which means that the surface structure
can significantly influence the total anisotropy. Hence, due to the large ratio of surface to
bulk atoms, the surface anisotropy of mNPs could be very significant, and the coating of
mNPs can therefore have a strong influence on their magnetic anisotropies. Different types
of anisotropy are often expressed simply as magnetic anisotropy energy (MAE), which
determines the stability of the magnetisation by describing the dependence of the internal
energy on the direction of spontaneous magnetisation. It has a strong effect on the values
of extrinsic properties.
Extrinsic properties of mNPs are not as essential as the intrinsic. They are derived
from long-range interactions and include magnetic coercivity and remnant magnetisation
(remanence), which are dependent on microstructural factors, such as the orientation of
intermetallic phases.
Magnetic coercivity, HC, can be described as a resistance of a magnetic material to
changes in magnetisation, and it is equivalent to the magnitude of the external magnetic
field needed to demagnetise material that has previously been magnetised to its saturation
point. Ferromagnetic mNPs that have reached saturation cannot return to zero magnetisa-
tion in the same direction once the applied field has been removed, and the magnetic field
is therefore applied in the opposite direction. This process leads to the creation of a loop
known as hysteresis. Hysteresis loops indicate the correlation between the magnetic field
and the induced flux density (B/H curves). Superparamagnetic mNPs each have only one
domain, and no hysteresis loop is obtained when the applied field is reversed. Remnant
magnetisation, Mr, is magnetisation left after the magnetic field has been removed. Once
the saturation has occurred and a magnetic field is no longer applied, ferromagnetic mNPs
will produce an auxiliary magnetic field and resist sudden change to remain magnetised.
In contrast, superparamagnetic mNPs will behave as paramagnets with instant need for
demagnetisation and negligible Mr. This property allows for ferromagnetic mNPs to gain
magnetic memory.
2.2. Biomedically Desired Properties of mNPs
Specifics of the application of interest govern the desired properties of materials used,
as was described briefly for the diagnostics and therapy methods in the previous section.
In biomedicine, the safety of the treatment towards a patient is the highest priority, and
hence superparamagnetic mNPs are preferred because they are magnetised only under
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the influence of an external magnetic field and quickly demagnetise otherwise, which
makes them safer for the human body. This implies that no coercive forces or remanence
exist, preventing magnetic interactions between particles and their aggregation, which
could lead to adverse problems derived from the formation of clots in the blood circulation
system. Saturation magnetisation is also a substantial factor for two reasons: (1) mNPs
with high MS show a more prominent response to the external magnetic field; (2) high
MS makes the movements of mNPs more controllable and guarantees efficient response
to the magnetic field, implying reduced time of residence and lower required dosages
of mNPs. MS is dependent on the mNP magnetic moment, size, and distribution, and
it is thus important to take them into consideration. An increase in size yields higher
MS, but above the critical diameter, mNPs become ferromagnetic and show undesired
behaviour due to the formation of agglomerates and magnetic memory. Moreover, very
small diameter sizes are highly desirable to reach regions of limited access; in order to
cross the blood–brain barrier, for example, a magnetic core size of d ≈ 12 nm or less is
required. Thus, a suitable balance should be found between the size distribution and
magnetic properties. Since mNP-based therapies work by directing the mNPs to a target
site using an external magnetic field, magnetic anisotropy is also a very important factor.
Alongside these general requirements that are applicable to all biomedical applications,
to enhance the performance of mNPs within MRI diagnostics and hyperthermia therapy it
is essential to gain insight into the inherent mechanisms behind their magnetic processes
and assess the properties of mNPs and external magnetic field parameters for optimal
treatment results.
2.2.1. Relevant Features in MRI
The mechanism of relaxation enhancement directed by MRI contrast agents arises
from the dynamic interactions of water molecules with the magnetic centres. Established
classical models have significantly contributed to the correlation between the contrast
agents’ properties and performance, paving the way to the smarter design of new materials.
These models are based on the interpretation of proton–electron interactions between water
protons and contrast agents, which is the most important mechanism behind the T1 and T2
contrasts within the contrast-agent-assisted MRI [186–188].
For contrast agents consisting of magnetic centre–ligand complexes, interacting water
protons are classified into inner-sphere, second-sphere, and outer-sphere protons, each
having distinct interaction mechanisms. The inner-sphere mechanism involves direct
magnetic centre–water coordination, whereas the second-sphere mechanism describes
interactions between the magnetic centre and water protons situated within the second
coordination sphere through hydrogen bonds. The outer sphere includes the influence of
the magnetic centre on the translational diffusion and rotational motion of the remaining
bulk water protons [97,189]. However, for contrast agents consisting of magnetic particles,
the direct coordination of water is atypical, and the largest share of the nuclear magnetic
relaxation of water protons in solutions (or suspensions) of magnetic particles arises
from pure magnetic interactions at the molecular level. In essence, this amounts to the
reformulation of the outer-sphere mechanisms from a single metal atom complex centre to
the solution of mNPs.
Superparamagnetic mNPs with large magnetic susceptibility produce local magnetic
fields under the influence of an external magnetic field. As a result, the local magnetic field
causes a perturbation in the motion and relaxation of nearby water protons. Hence, the
relaxation is induced by the fluctuating dipolar interaction between the nuclear magnetic
moment of the water proton and the global magnetic moment of the mNP, just as in the
case of classical outer-sphere theory. This reformed outer-sphere theory now describes
the change in the relaxation of solvent protons as the water molecules diffuse into the
neighbourhood of a solute particle and start interacting with its magnetic dipolar moment.
This type of local perturbation shortens the T2 relaxation time, also known as spin–spin
relaxation, of water protons during water diffusion. The mNP contrast agent catalytically
Materials 2021, 14, 3611 10 of 50
relaxes water protons at the particle–solvent interface emanating in T2-weighted MRI
images. The extent to which the mNP contrast agent affects the relaxation rate of tissue
water can be quantitatively characterised by its transversal relaxivity, rCA, and the final








mNP relaxivity is thus defined as a proportionality constant between the induced
increase in the relaxation rate of the tissue and the concentration of the contrast agent, [CA].
By definition, low doses of high-relaxivity contrast agents provide an equivalent contrast
magnification as higher concentrations of contrast agents with inferior rCA. Every tissue
has an inherent relaxation rate, 1/To2 , and in order to generate an observable contrast, the
relaxivity of the contrast agent should be at least at 10% of the inherent rate.
Outer-sphere theory for T2 relaxivity has developed an expression for the depen-
dence of relaxivity performance of superparamagnetic mNPs on their intrinsic properties—








where κγ is the constant derived from the gyromagnetic ratio of solvent protons, Veff is the
effective volume fraction (V/ [CA]), Ms is the saturation magnetisation, r is the radius of
the magnetic core, l is the thickness of impermeable mNP coating, and D is the diffusion
coefficient of water molecules. Viewed simplistically, an increased Ms value is reflected
in the increased response of mNP contrast agents to be magnetised by the external field,
resulting in the higher r2 relaxivity. Similarly, improved relaxivities can be achieved with a
larger magnetic core radius. As the proton relaxation occurs mainly at the interface of the
mNP and surrounding aqueous environment, nanoparticle coatings also influence the rate
of T2 relaxation through the coating thickness.
T2 relaxation processes occur through three mechanisms. The first mechanism, known
as Curie spin relaxation, arises from the dipolar interactions between water protons and
a large magnetic moment of unpaired mNP electrons. It depends on the strength of the
applied magnetic field and is a function of the size and water diffusion time, r2/4D. This
mechanism is prominent for small-sized mNP contrast agents under strong fields, while
it decreases rapidly for larger mNPs where T2 relaxation is mostly dominated by the
remaining two mechanisms: dipole–dipole coupling between metal ions and hydrogen
nuclei and scalar or contact relaxation processes. Hence, a primary factor affecting r2 is
the mNP-generated inhomogeneity, which depends largely on the magnetisation of the
contrast agent. In general, more efficient inhomogeneity originates from materials with
higher saturation magnetisation; such materials can also influence a greater volume of
surrounding water. However, the effective magnetisation value of mNPs is often several
times lower than that of the bulk counterpart, caused primarily by an increased magnetic
anisotropy. Due to the presence of magnetically ‘dead’ or tilted layers of atoms on the
mNP surface, the surface atomic spins are largely canted, thereby enhancing the MAE and
reducing overall magnetisation. This effect is especially pronounced in small particles,
owing to their high surface-to-volume ratio. Additionally, MAE is also affected by the
mNP morphology and surface interactions. For particles of the same volume, a reduced
shape and surface anisotropy lead to the spin state similarity between the surface and core,
thereby increasing the magnetisation. Contact interfaces between two different magnetic
phases, for example in the form of core–shell NPs, often provide an additional source of
anisotropy (exchange anisotropy), resulting in a slight reduction but also in stabilisation of
magnetisation and improved coercivity. Moreover, changes in the magnetic moments of
surface atoms can be enforced through surface functionalisation.
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Diffusion dynamics of water molecules in the magnetic field gradients is another
important factor for effective r2 rates. It is characterised by the number of water molecules
that have diffused into close proximity of the interface with the contrast agent and their
residency time within that region. mNPs with large magnetic moments have a stronger
tendency to form dipole interactions with water protons, to form a larger area of influence,
and to provide a greater possibility of relaxing the diffused water molecules. Certain
coatings can also be beneficial in this matter, while others may hinder water diffusion or
prolong water residency within ligand pockets, reducing the image contrast. Coatings
forming a hydrophilic mNP surface favour diffusion and retention of water molecules
in the mNP outer-sphere. Finally, fine-tuning of the thickness, charge (ligands rich in
π-electrons create small magnetic fields increasing inhomogeneity), and porosity of the
coating allows for optimised water accessibility and residency.
Hence, the dynamic interactions behind the relaxation mechanisms depend predomi-
nantly on the magnetic properties of mNP contrast agents, which, in turn, are attributed
to a large extent to the mNP structural features. Relaxivity of superparamagnetic mNPs
can be enhanced not only via their magnetic properties, but also through the coating
optimisation. The last parameter directly included in the equation, without specifically
considering its effect on the magnetic properties, is the diameter of the magnetic core.
From the relationship, the r2 value can be increased by increasing the core size. However,
biomedical applications are limited by the superparamagnetic size limit. Within this critical
diameter, theoretical studies have identified three mNP size regimes depending on the
r2 rate trends: the motional average regime (MAR), the static dephasing regime (SDR),
and the echo-limiting regime (ELR) [190]. With the growing mNP size in the MAR regime,
relaxivity increases, reaching a plateau in the SDR regime. With any further size incre-
ment, mNPs fall in the ELR regime where r2 steeply decreases. Accordingly, the highest
r2 is achieved for mNPs within the SDR, but nanoparticulate contrast agents employed
thus far have been within the MAR regime to limit the NP aggregation through magnetic
interactions [191,192].
Finally, in nanoparticle-based imaging, higher mNP concentrations lead to an im-
proved signal-to-noise contrast, at a cost of a toxicity trade-off. Therefore, even though
it does not directly affect the relaxivity constant, mNP concentration is one of the most
important parameters in the development of nanoparticulate contrast agents, with the
objective of obtaining sufficient contrast at the safest (lowest) mNP concentrations. Studies
on SPIONs have consistently shown significant enhancement in the MRI signal when
the concentration of Fe progresses from 9 to 100 µg/mL [193–195], and the minimum
concentration found to produce marked hypointense signals was evaluated at or above
22.4 µg/mL [196]. Moreover, upon 24 h incubation, Mn-doped SPIONs displayed no
appreciable cytotoxicity even at the highest metal ion concentrations, indicating good
biocompatibility [193]. Furthermore, the sensitivity of the imaging technique must also be
taken into account. So far, the most sensitive detection experiments on mNP imaging have
demonstrated sensitivity to particle concentrations in the picomolar and tens of picomolars
range. For example, the tissue T2 contrast is clearly distinguished at gold-coated Co mNP
concentrations as low as 50 pM [55]. This detection threshold is 7 orders of magnitude
better than those for monocrystalline iron oxide particles, whereas the T2 relaxivity per-
particle concentration is improved up to 5 orders of magnitude compared to both magnetite
and Fe/Au NPs [197,198], which translates into lower mNP concentrations for efficient
MRI contrast.
2.2.2. Relevant Features in Hyperthermia
The heating efficiency of the magnetic nanoparticle hyperthermia process depends
on the power dissipated by the mNP following the application of an alternating magnetic
field, and it is often quantified through the specific absorption rate (SAR). SAR is the
rate at which the power is absorbed by a volume of dielectric material, such as biological
tissue, exposed to electromagnetic radiation (or another source of energy). It is often
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mentioned interchangeably with the specific heating power (SHP), which is defined as the
thermal power per unit mass dissipated by the magnetic material and accurately describes
a material’s heating efficiency. The interconversion of magnetic field energy into heat
by mNPs can arise through three mechanisms: eddy currents, hysteresis, and relaxation
processes. Eddy currents are loops of localised electric current induced by the varying
magnetic field. Their existence depends on how resistant the material is towards current
heating, and they are usually present in bulk crystals. The prevailing heating mechanism
in multidomain mNPs is hysteresis loss, while single-domain superparamagnetic mNPs
have high electrical resistivity, and such power loss is thus negligible compared to that
originating from relaxation processes. Relaxation mechanisms have two modes: following
the removal of the external magnetic field, magnetic moments relax either through the
motion of the internal spin (Néel relaxation) or by the rotation of the mNP around its
own axis (Brownian relaxation). Either relaxation of the magnetic moment back to the
initial position releases thermal energy and induces local heating due to friction. If the
mNP undergoes Néel relaxation, heat is dissipated by the rearrangement of atomic dipole
moments where internal friction causes phase lagging between the applied field and
magnetic moments. If the mNP relaxes through a Brownian relaxation mechanism, the
power loss arises from the shear stress in the surrounding medium. Additional power loss
can occur due to the physical relaxation of the liquid.








where ω is the angular frequency of the external magnetic field and equals ω = 2π f , µ0 is
the magnetic permeability constant of free space, χ0 is the magnetic susceptibility, and H
is the magnitude of the external magnetic field. The fractional term leads to the maximal
power at ωτ = 1; in this case, the matching ω is called a critical frequency. An estimated
goal for the material development in this field is an SHP of the order of 1000 Wg−1, based on
the amount of mNPs that can be incorporated by a single living cell [16]. The critical factor
is hence the relaxation time of mNPs, τ, resulting from prevailing heating mechanisms.
Relaxation time can be defined as the time needed for magnetic moments of mNPs
to vanish once the external magnetic field has been shut off. For Néel relaxation, the
time constant of the external magnetic field is short enough so that magnetic moment
alternates from parallel to antiparallel orientation and back without a change in the physical
orientation of the particle. As excitation occurs against the anisotropy energy barrier,
the process strongly depends on mNP volume and anisotropic properties, and it is not
influenced by the conditions of the surrounding environment. The relaxation time for Néel









where τ0 is the characteristic relaxation time and equals τ0 = 1/ f0 ( f0 = 109 − 1013 s−1), k is
the Boltzmann constant, T is the temperature, K is the anisotropy constant (includes all
sources of anisotropy), and V is the volume of the mNP. KV is somehow equivalent to an
activation energy that has to be exceeded by the thermal energy, kT, to overcome the inher-
ent magnetic anisotropy energy barrier. In contrast, Brownian relaxation prevails when
magnetic anisotropy is sufficient to overcome inertial resistance, in which case the external
magnetic field causes rotation of a whole particle with the magnetic moment remaining
fixed relative to the crystal axis. The Brownian relaxation time is highly dependent on the
hydrodynamic properties of both mNP and surrounding medium, such as viscosity of the
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fluid and hydrodynamic volume of mNP, which includes any surfactant layer added for





where η is the viscosity of the medium and VH is the hydrodynamic volume of mNPs.
When these two processes are simultaneously involved, the effective relaxation time, which
describes the energy transfer rate, takes both into consideration, and the final expression










Overall, the shorter of the two dominates the effective relaxation time—Néel for small
particles in viscous solutions and Brownian for particles with large hydrodynamic volume
in an environment of lower viscosity. The exact division between mechanisms depends on
the anisotropy constant of each material. In magnetic nanoparticle hyperthermia, mNPs are
embedded in a tumorous tissue and internalised by cancer cells, either by adhesion to the
cell walls or in the form of the restraint of movement provided by cell plasma. Because of
this immobilisation, Brownian mechanism is damped to the maximum and Néel relaxation
occurs almost exclusively [199].
mNPs can be remagnetised only after their relaxation is completed; therefore, the
frequency of the external field has to match the relaxation time in order to obtain efficient
heating rates. SHP is maximised under the condition ωτ = 1, and since typical Brownian
relaxation times in systems where this mechanism dominates over Néel relaxation are
around 10−5 s, effective frequencies would need to be 105 rad s−1 (15 kHz), which is
much lower than any frequency reported in hyperthermia studies (100–300 kHz range)
and therefore favours relaxation times of 10−6 s or below [139,200]. This confirms Néel
relaxation as the predominant heating mechanism in magnetic nanoparticle hyperthermia
and accentuates the need for magnetic anisotropy energies that significantly exceed the
thermal energy (KV  kT); if the anisotropy constant is not satisfactory, no noteworthy
heating is expected. Therefore, SHP depends on the size, magnetisation, and anisotropy of
mNPs, as well as on the characteristics of the applied external magnetic field.
From the equation for τN , MAE is an important factor in enhancing the Néel relaxation
time. However, within the limitation of ωτ = 1 to maximise SHP, an enhancement of
the relaxation time may not always yield higher SHP values, and the frequency of the
external magnetic field must be chosen accordingly [139]. Only through that correlation
can efforts to increase the MAE of mNPs yield a higher heating efficiency and, ultimately,
by satisfying the ωτ = 1 condition, allow for the use of lower frequencies of the applied
magnetic field [201].
Magnetic nanoparticle hyperthermia involves the excitation of mNPs suspended in a
fluid medium using the external magnetic field, meaning that parameters of the magnetic
field itself should also be optimised to obtain the desired results. Changes in frequencies
and amplitudes directly and proportionally influence the heating power of mNPs, where
SHP increases rapidly with the increase in the strength of the magnetic field. Enough
heating power must be generated for the destruction of cancerous tissue, while at the same
time the frequency and strength of the applied magnetic field have to be safe for the human
body. These requirements force strict limitations on the frequencies to range from 0.05 to
1.2 MHz and the magnetic field strengths to range from 0 to 15 kA m−1. Higher values
would lead to serious problems, such as aggregation of mNPs causing embolisms, while
lower frequencies would stimulate skeletal, cardiac, and peripheral muscles and trigger
arrhythmias. Amplitudes are usually in the range of 5–30 kA m−1 and external magnetic
fields with H0 × f less than 4.85 × 108 A m−1 s−1 have been approved for successful use
in humans [202].
Theoretically, SHP cannot be controlled by the mNP concentration because they show
no obvious interdependence; however, higher mNP concentrations provide more efficient
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hyperthermia performance as less time is required to reach optimal temperatures. The con-
dition of sufficient heat generation by mNPs to sustain tissue temperature of at least 42 ◦C
for ~30 min was achieved in different studies by using SPION concentrations in the 0.1 to
400 mg/mL range, significantly higher than when used as T2 contrast agents [116,203–206].
Nonetheless, according to several recent reports, it was surprisingly observed that SHP
and SAR values can be affected by mNP concentration, contrary to the invariance for
6–300 mg/mL measured for mNPs dispersed in water [207]. The physical principle of
SHP oscillations was explained by the interparticle magnetic dipole and mutual potential
energy interactions, dividing the dependence into four concentration regions. In the region
of the lowest concentrations (<0.1 mg(Fe)/mL), the nanofluids showed the highest SHP; in
region 0.1–1.0 mg(Fe)/mL, a remarkable drop in SHP was observed; at 1.0–10 mg(Fe)/mL,
the SHP was increased again; and at the highest concentrations (10 mg(Fe)/mL or more),
the SHP was re-decreased [135,208].
Different combinations of superparamagnetic materials and biocompatible ligands
have been investigated, but achieved efficiencies are far from ideal and further efforts
are directed to find the best nanocomposites. The most important advance in the last
10 years was the commencement of the first-ever clinical studies of therapeutic hyperther-
mia induced by magnetic NP heating [121]. The study successfully demonstrated that
magnetite NPs can be safely applied in the treatment of brain tumours and that hyperther-
mic temperatures are achieved. Magnetite and maghemite NPs exhibit (up to this point)
medium heating efficiency with little or no control of temperature changes when compared
to other magnetic materials, but their biocompatibility, nontoxicity, and ability to escape
the reticuloendothelial system makes them preferred candidate NPs for magnetic hyper-
thermia. However, the relatively low heating rates of conventional SPION hyperthermia
agents [137] (less than 100 W g−1 for 400 kHz frequency and 10 kA m−1 magnetic field
strength) unfortunately often require a high mNP concentration, which would not only
result in potential toxicity but also complicate the monitoring of the progress of tumor
response using imaging tools, thus promoting the implementation of mNPs with higher
specific magnetisation. Many efforts have been made in order to improve the properties
of magnetite NPs; a valuable strategy was to increase their MAE by the total or partial
substitution of Fe2+ ions by Co2+ ions. Cobalt ferrites have shown comparatively high
thermal and oxidative stability with higher suitable MAE and consistently large heating
effects with SHP values reaching 720 W g−1, which is significantly higher than the rates
reported for the iron oxide NPs (22–200 W g−1 [209–211]). The current focus of research is
on cobalt mNPs to further improve the heating efficiency in hyperthermia therapy.
2.2.3. Relevant Features in Drug Delivery
Magnetic targeting of drug delivery carriers is based on the attraction of mNPs induced
by an external field. For the mNP drug carrier to be efficiently trapped in the magnetic field
at the targeted site, the gradient of the magnetic field has to exert a sufficient translational
force on the particle–drug complex. This magnetic force, Fmag, can be expressed as:




where χ1,2 are the magnetic susceptibilities of the medium and the mNP, V is the volume
of mNPs, µ0 is the magnetic constant, B is the strength of the magnetic field, and ∇B is the
field gradient. The susceptibility of the biological medium is usually very small compared
to that of mNPs and can be disregarded. From the expression, the effective capture of the
mNPs depends on the magnetic properties and volume of the particles, as well as on the
parameters of the applied magnetic field. As the magnetisation of the mNP decreases, the
ability of the magnetic field to capture and direct them also decreases. Correspondingly,
insufficient field strengths and gradients have limited penetration depth and generate
weak translational force. Estimations from experimental studies and extended theoretical
investigation of the hydrodynamic conditions of mNP drug carrier targeting have indicated
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that a minimal field strength of 200–700 mT is required at the target site with gradients
along the z-axis of approximately 8–100 T/m depending on the flow rate [126,127].
3. Computational Modelling of mNPs
For the optimal performance of mNPs in biomedical applications, it is important that
they are biocompatible and nontoxic and have colloidal stability, opportune surface modi-
fication, an appropriate particle size, and, above all, adequate magnetic properties. The
dependence of magnetic properties on the structural parameters of mNPs, namely their size
and shape, is well known, with paramount examples in the literature [212–218]. However,
the determination of this correlation is by no means easy or exempt from complications.
Even with advances in the control over the synthesis and characterisation, an ever-present
distribution of mNP sizes ultimately prevents the assignment of specific magnetic features
to a particular size or morphology. Furthermore, capping agents increase the complexity
of the system, adding even more uncertainty to the assignment of the origin of specific
magnetic behaviour. These impediments in the determination of a specific connection be-
tween the mNP morphology, coating, and magnetisation are a substantial limitation in the
development of property-tuning strategies, which are an ultimate tool in the engineering of
mNPs for specific applications. It is in this sense that computational modelling becomes a
powerful complementary technique to experiment, by unravelling the connection between
the properties of mNPs and their structural factors.
The modelling of isolated monometallic mNPs is only limited by the availability of
sufficient computational resources, and quantum mechanical calculations have become
the standard technique to obtain properties of clusters and smaller mNPs of up to a few
hundred atoms [219–227]. The acquisition of resources for quantum simulations can be
problematic for larger mNPs with more realistic diameters that are closer to application-
relevant sizes. For simulations of such mNPs with hundreds or thousands of atoms,
approximate theoretical models have been designed, based on classical interatomic po-
tentials with parameters that were fitted either to the experimentally captured properties
or to the descriptors obtained through quantum density functional theory (DFT) calcula-
tions [228–233]. It is the quality of these parameters, as assessed by their ability to estimate
closely the values of targeted data, that ultimately determines the accuracy of the results
obtained from molecular simulations. Despite the success of classical molecular dynamics
(MD) in describing the behaviour of large mNPs, the need to predefine fixed interaction
potentials in the form of a force field remains a significant challenge for metallic species
and their interaction with different capping agents [234–237]. The lack of the description
of bond breaking/forming at the MD level is also hampering any investigation of the
mNP reactivity. Additionally, even after the sufficient potentials for a specific system of
interest have been elaborated, changing a single species provokes enormous efforts to
suitably reparameterise the potential energy function. As a result, systematic studies are
a tour de force if consistent potentials are not already available. However, the advent of
highly parallelised supercomputers has gone side-by-side with the progress in ab initio DFT
methods, expanding the initial studies of small gas-phase metal clusters to investigations
of large mNPs and their interaction with protective coatings [238–243].
This review focuses on the computational modelling of cobalt mNPs as tackled mostly
by means of DFT calculations, which has aided insight into the link between their structural
and magnetic properties. It is our aim to show that these studies can provide important
information to allow reliable predictions of mNP performance within biomedical applica-
tions. They provide a useful gateway before attempting a rational, engineered tuning of
the magnetisation of Co mNPs, and they may result in a sound modelling approach for
magnetic mNPs of varying compositions as they rely only on ab initio inputs of physical
constants. Coating and alloying effects are also contemplated, as changes in the magnetic
behaviour can be induced by an active interplay between the surfactants and mNPs or
between different metallic phases.
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A physical description and expressions of observed NP phenomena (magnetic relax-
ation, heat dissipation, etc.) helped to identify factors affecting material capabilities and
the treatment outcomes. Incorporation of ab initio models in the research efforts to opti-
mise these factors within magnetic nanosystems could hence facilitate tuning strategies of
application-specific properties to acquire the maximum treatment efficacy, and DFT results
are often implemented in extended Monte Carlo simulations or analytical and numerical
models to quantify magnetic field response, proton relaxation, or heat transfer [244–247].
However, it is important to note that the optimum property settings to generate maximum
relaxation or heating through analytically developed expressions cannot ensure clinical
suitability, as the optimisation process is often based on a number of assumptions that
may deviate in real-life applications [248]. Even in vivo and in vitro studies sometimes give
conflicting results [249–251], and DFT predictions and accompanying optimisation models
must hence be verified by clinical data.
3.1. Monometallic mNPs
3.1.1. Cluster Model
The simulation and description of nanosized metallic systems essentially begin by
modelling clusters with a small number of atoms. Quite often, exhaustive efforts to define
the cluster structure belonging to the global energy minimum of a certain atomic size (note
that the number of possible configurations grows exponentially with the number of atoms)
can be simplified by implementing a molecular dynamics simulation. Rives et al. [252] and
Rodríguez-López et al. [253] have captured corresponding growth structures for small Co
clusters using different potential parameters. Both found an icosahedral growth pattern for
the global minimum energy structure with hcp and fcc structures dominating in particular
sizes, whereas for the second isomer, distorted icosahedral structures were generally
obtained. However, MD-based methods lack the electron-level description necessary for
the determination of magnetic behaviour and bond forming and breaking, and hence
their use beyond the identification of suitably stable structures is rather limited. Hence,
knowledge of electronic structures obtainable through quantum mechanical methods, such
as those based on the DFT, is required.
DFT results for a number of chosen morphologies will in the majority of cases show
good agreement with the MD trends, and the magnetic properties or reactivity behaviour of
those structures can be investigated further on the quantum level. The MD-DFT agreement
in the stability trends of a convenient number of shapes (convenient in respect of DFT
computational cost and exploration of the global minimum well) for each cluster size in
the case of Co clusters can be seen in multiple studies, with a few examples shown in
Figure 3 [239,253,254]. The second energy difference in the total energy of successive cluster
sizes also captures the ability of DFT calculations to reproduce the stable morphologies
across the range of cluster sizes (Figure 4).
Small clusters efficiently capture the large surface-to-volume ratio effects on the
magnetic and electronic properties, but these observables generally show strong oscillations
with the number of atoms per cluster. Such small clusters are known as systems where
every atom counts, and an estimation of the properties of a particular cluster size from
the characteristics of the neighbouring sized clusters is often misleading. Fortunately,
electronic structure features for the couple-atom systems are easily obtainable within the
DFT approaches [255–261].
Because of the property oscillations, which are also heavily dependent on the type
of metal atoms that constitute the cluster, a universal description of the progression of
magnetic moment, or any other property, does not exist. The closest researchers have come
to a unifying picture of metal clusters is the closed-shell model, which is manifested through
the filling of electronic shells resulting in clusters of extraordinary stability [262–264]. The
numbers of electrons corresponding to closed electron shells in metal clusters are 8, 20,
40, 58, etc. This model can often be extended to clusters with geometrically closed shells
that often adopt ‘perfect’ structural shapes, such as 13-atom icosahedron. However, the
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closed-shell model cannot account for a large number of cluster sizes and their structural
isomers that are between the clusters with a relevant number of atoms sufficient to form
closed electronic or geometric shells. This rich variety of conformational isomers, which
often exists within a narrow energy range, and the unique set of properties for each added
atom translate into a rather complex issue in the electronic and magnetic structures for
small metal clusters [265].
Figure 3. Agreement between most stable cluster structures of 6-, 8-, and 14-atom Co as predicted
by DFT [239,254] and MD [252,253] simulations. For DFT studies, energy difference between the
structural isomers is given in the square brackets in eV.
Figure 4. Relative energy stability of successive Co cluster sizes expressed as a second difference
in total energy, ∆E2, as predicted by DFT (Datta (2007) and Farkaš (2020) [239,254]) and MD (Rives
(2008) and Rodriguez (2003) [252,253]) simulations.
Magnetic properties, namely magnetic moments per Co atom and magnetic anisotropy
energies of small Co clusters (2 ≤ N ≤ 30), are shown in Figure 5. Anything better than a
general agreement between experiment and theory is hardly achievable, primarily owing to
the deficiency in DFT treatment of the orbital moments, which can be rather large in clusters,
in contrast to the bulk metal where they are strongly suppressed [266]. Recent findings
of orbital moments in small Co clusters of an order of magnitude higher than those in
the bulk further confirm this [267]. Additionally, experimental measurements of magnetic
moments also suffer from rapid decrease in the cluster beam intensities, thermalisation,
and changes in the direction of magnetisation in response to thermal fluctuations [268–271].
Inconsistencies in the experimental and computed trends can be improved for intermediate
sizes (10 ≤ N ≤ 25) by introducing magnetic moments of the second most stable isomer,
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confirming the possible coexistence of different isomers in the cluster beam, which was
proposed experimentally [268].
Figure 5. Experimental data are taken from Knickelbein (2006) [270] () and Xu (2005) [271] (), DFT
data from Farkaš (2020) [239]. Legend is the same for both graphs.
Generally, clusters in this size range show significantly increased values of the mag-
netic moment and MAE compared to the bulk counterparts (1.72/1.64 µB and 27.2/1.7 µeV
MAE per atom for hcp/fcc Co bulk), but the degree of increase is size-dependent. Neverthe-
less, the differences between magnetic properties of Co clusters and bulk are more a matter
of degree than a matter of type, as they are both composed of atoms whose electronic
character (i.e., number of unpaired electrons) is responsible for their magnetism. Only in
rare instances do metal clusters and metal bulk phases show inverse behaviour [272]. The
degree of the cluster’s magnetic character depends on the spin coupling of composing
atoms, and, as seen in Figure 5, no obvious magnetic moment or MAE trends exist as the
cluster size progresses towards a couple of tens of atoms.
In contrast, the chemical properties of small clusters are a combination of the reactivity
of bulk and molecular matter, and any general conclusion cannot be simply extrapolated
from the bulk behaviour. Similar to the magnetic properties, small and medium clusters
show different reactivities that do not vary smoothly with size. Oscillations in the adsorp-
tion energies of oxygen on the small Co clusters in the 2 ≤ N ≤ 30 range are shown in
Figure 6. At instances, groups of cluster sizes with resembling geometries, such as N = 4–7
or N = 15–19, also show similar adsorption behaviour for atomic adsorbates.
Figure 6. DFT-calculated adsorption energies for single-atom oxygen adsorption on small (2 ≤N ≤ 30)
Co clusters.
However, two different geometric forms of the cluster of a single size often have
different reactivities, similarly to the distinct properties of molecules with the same el-
emental composition but different conformation (chemical isomers). For example, the
computed adsorption energy of an oxygen atom on the six-atom cluster with Oh symmetry
is −2.79 eV, whereas the same quantity on the six-atom cluster with C2v symmetry is only
−1.29 eV. Similarly, 18-atom clusters with icosahedral and hexagonal geometries yielded
Eads of −2.88 and −3.38 eV, respectively. It is also not unusual for several cluster sizes and
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morphologies to induce dissociation of certain molecules, whereas the rest of the cluster
systems facilitate plain adsorption [273].
These observations have led to the formulation of what is today known as the non-
scalable regime, where chemical and physical properties of clusters cannot be predicted
through size-correlated trends but are instead completely independent for each number of
atoms. Any system showing such autonomous behaviour and belonging to the series of
sizes where trends, if any, are captured with great difficulty, should never be referred to
as a metal NP, but rather as a metal cluster or a nanocluster, and as such cannot represent
realistic behaviour of nanoparticles.
3.1.2. Surface Model
Metal clusters have, nevertheless, been employed as models for metal surfaces and
NPs owing to the confined number of atoms, which was easy to simulate by employ-
ing the most sophisticated and accurate quantum methods [274–276]. However, even
though these models were useful for insights into the adsorbate–metal atom interactions,
a cluster representation results in an increased number of undercoordinated metal sites,
which often translates into unrealistic surface or NP electronic properties and chemical
activities [277–279]. Consequently, cluster representations have been abandoned, giving
place to the extended slab models obtained at the extent of the metal surface periodicity.
The periodic slab model has quickly become the standard for theoretical studies of
surface chemistry, and it was believed that a complete description of mNPs can be gained
through such simulations if mNPs are considered as a sum of discrete facets [280–285]. For
example, for those Co cluster sizes with hexagonal symmetry which showed sufficient
surface expansion so that the atomic adsorbate can bind to the cluster solely through the
facet sites without interacting with any of the undercoordinated atoms (22 ≤ N ≤ 30), the
calculated facet adsorption strength (between −3.06 and −3.54 eV) coincides with the
adsorption on the extended slab system (Eads = −3.12 eV). Since the chemical reactivity
of facets of relatively small metallic clusters can be envisioned by employing extended
slab models, this should also hold for large mNPs with significantly larger surface areas.
Nevertheless, there is still a high level of uncertainty when considering these models as
reliable representations of the changes in the electronic properties of mNPs upon chemi-
cal adsorption.
For cobalt, both fcc- and hcp-bulk phases can be a basis for the mNP construction.




as the most prominent
surfaces, while the (111) surface dominates the mNPs of the fcc framework. Average
magnetic moments of slab surface models are naturally going to show values closer to
the bulk magnetisation than to the moments of cluster systems considering the complete
absence of any undercoordinated sites. However, layer-by-layer progression of magnetic
moments from the top-most surface atoms towards the bulk-like inner atoms of the slab
model is often taken as an indication of the shell-to-core progression of magnetic behaviour
of larger, facet-saturated mNPs. Magnetic moments of different layers are shown for the
three populated surfaces in Figure 7 (left). A 5–8% reduction in the magnetic moment of
Co atoms is captured when going from the surface to the inner, bulk-like atomic layers. An
obvious deficiency in slab representation of shell-to-core progression of magnetic moments
is the planar contact point between the atoms placed in different atomic layers as opposed
to the radial distribution of atoms within the real mNP.
Upon adsorption of a full monolayer (ML) of oxygen (where full monolayer or 1.00 ML
is established when the number of interacting atomic adsorbates corresponds to the number
of Co atoms in the surface layer), the distribution of magnetic moments between the layers
significantly changes (Figure 7, right). Hcp (0001) and fcc (111) surfaces are flat in the
sense that the closest Co atoms are levelled within a straight plane and adsorption takes




surface has a row-like
arrangement and allows channel-driven adsorption or even stimulates the subsurface
adsorption with minimum energy cost. This significantly influences the induced change in
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the magnetic moments of surface atoms—for the (0001) and (111) surface, the top-most
surface Co atoms experience a reduction in magnetic moments. In the case of the (0001)
surface, an 85% decrease in magnetic moment is observed, with a 5–10% reduction in the
remaining atomic layers. On the (111) surface with lower packing density, there is a 20%
decrease for the first-layer atoms and a 15–30% increase in the inner slab layers. Magnetic




surface atoms, on the other hand, have 15–40% higher
values after adsorption, and a similar rate of increase is observed for the third atomic layer
upon the in-channel incorporation of adsorbate atoms.
Figure 7. Magnetic moment per Co atom, µ, as a function of the atomic layer within the extended




, and fcc (111) surfaces of metallic cobalt—left: bare surfaces,
right: oxidised surfaces. Layers are numbered going from bulk to the surface, 1 being the bulk-like
inside layer and 5 being the top-most surface layer.
However, the effect of adsorption on the magnetic moments is a complex, site-
dependent issue, and different atoms within the same layer might experience varying
cumulative effects of adsorbate atoms or molecules [286–288]. Atom-decomposed proper-
ties can hence reveal more details on adsorbate–surface coupling and the magnetic nature
of the oxidative layer. For oxidative adsorbates, such as atomic oxygen, saturation of the
metallic surface can easily lead towards the formation of a metal oxide skin [289–294].
Metal oxides often show significantly distinct magnetic properties from their parent metal
materials, which can be unfavourable for many applications.
Experimental studies of cobalt oxidation have observed the growth of cobalt oxides
in the (111) direction on the (0001) surface of hcp Co [295]. The top panel of Figure 8
shows optimised magnetic ordering of the (0001) surface with different oxygen coverages
and the Co3O4 (111) surface as modelled by the Hubbard-corrected generalised gradient
approximation, GGA + U (Ueff = 3.0 eV) with accompanying densities of state (DOS).
GGA + U is known to accurately capture the electronic and magnetic nature of metallic
oxides and corresponding metal–oxygen structures, as also shown specifically for cobalt in
the literature [296–299]. CoO is known to have antiferromagnetic ordering of type II (AF-II)
as the most stable magnetic ordering below its Néel temperature (210 K) [300,301]. Co3O4
has magnetically active Co2+ ions located in the tetrahedral sites, while octahedral Co3+ ions
do not have a permanent magnetic moment [302,303]. Bellow the Néel temperature (∼40 K),
the antiparallel magnetic ordering within the tetrahedral sublattice of Co3O4, due to the lack
of magnetic carriers in the octahedral positions, yields a fairly low material magnetisation.
Hence, oxidation at room temperature indicates a partial loss of magnetisation upon the
formation of magnetically dead cobalt oxide layers on the surface.
Initial oxygen adsorption on the (0001) surface, represented by low adsorbate cover-
ages (0.33 ML), results in a detectable prolongation of Co–Co bonds between the oxygen-
interacting and remaining Co atoms without changing the ferromagnetic nature of the
cobalt surface. An increase in the magnetic moments of Co atoms that bind to oxygen
(dCo–O = 1.95 Å) is captured at 1.98 to 2.06 µB, with 2.37 µB calculated for the elevated Co
atom. This corresponds well to the experimental suggestions of Co–O formation with CoO
character and an expanded intralayer lattice parameter [304], where the Co–O distance
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at the (111) surface of CoO is approximately 1.85 Å and magnetic moments of Co atoms
range from 2.30 to 2.60 µB. For medium coverages (0.67 ML), oxygen atoms adsorbed such
that three aligned surface Co atoms each formed bonds with three O atoms. Predicted
magnetic coupling consists of Co atoms bonded to three O atoms which have spin down
antiferromagnetic orientation and significantly reduced magnetic moments of 0.50–0.68 µB,
whilst the rest are oriented spin up and show values of 1.20–1.85 µB. Finally, the optimised
structure at full monolayer (1.00 ML) oxygen coverage, including bond lengths, DOS,
magnetic moments, and magnetic orderings, implies the initialisation of continuous oxide
formation on the (0001) surface. The full first layer is predicted to have minimal magneti-
sation of 0.35 µB with ferromagnetic coupling. The main 2p O and 3d Co hybridisation
peaks are situated between −0.5 and −2.0 eV, and between −4.0 and −5.0 eV, which is
consistent with the nonmagnetic Co(III) ions of Co3O4. Changes in the magnetic moments
of second-layer cobalt atoms are within 0.20 µB for any oxygen coverage.





surface (bottom panel) as computed by GGA + U; orderings of predicted directions
of cobalt oxide growth are provided on the right. Below structures, pDOS in a.u. (range −2.5 to
2.5 states/eV) for 3d orbitals of each distinguishable Co surface atom and 2p orbitals of O atoms.
Grey, dark blue, and light blue spheres represent Co (II) up spin, Co (II) down spin, and Co (III)
atoms, respectively, with oxygen shown as red spheres.
Oxidation of the (1011) surface has not as yet been probed experimentally. The bottom
panel of Figure 8 shows optimised magnetic ordering of the (1011) surface with different
oxygen coverages as modelled by GGA+U (Ueff = 3.0 eV) plus accompanying DOS. For
coverages of half a monolayer (0.50 ML) or less, no changes in the ferromagnetic cou-
pling of surface cobalt atoms are observed and the calculated magnetic moments are in
the range of 1.91–2.23 µB. For higher coverages (0.75 ML), the results show changes in
the magnetic coupling of certain surface atoms, with a further increase in the magnetic
moments to 2.25–2.66 µB. At full monolayer coverage (1.00 ML), half of the surface atoms
had antiferromagnetic coupling and magnetic moments of 2.38–2.55 µB, while the rest expe-
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rienced ferromagnetic coupling with reduced magnetic moments at values of 1.88–2.20 µB.
Because of the integration of adsorbate atoms in the structurally arranged rows on the
surface, deeper layer Co atoms also feel the presence of oxygen, causing enhancement of
the magnetic moments to 1.85–1.95 µB.
Reconstruction of the initial row-like geometry of the (1011) surface through the full
monolayer oxygen adsorption indicates that the orientation of the cobalt oxide growth
would more likely be through the CoO (011) or CoO (100) surfaces compared to the (111)





hcp Co surface towards the centred lattice of the CoO (100)
plane [305] through movement of Co atoms and centring of the adsorbed oxygen between





surface, because of the prolonged Co–Co distances, further reconstruction
towards the CoO (100) faceting is not to be expected on the (1011) Co surface since already
at 1.00 ML certain oxygen atoms were unable to form bonds with more than two surface
atoms. Therefore, the (011) surface was suggested as the orientation of CoO growth on the
(1011) surface.
Decomposition of oxygen-induced magnetic effects on an atom-to-atom basis thus
allows for precise insight into the nature of the oxidised surface layer, which can be
used to predict the directional growth of oxide phases as well as further changes in the
magnetic moments of slab layers. Similar to the layer progression of magnetic moments
for bare slabs, oxygenated surfaces also suffer from the directional aspect of established
interactions, where planar adsorption of oxygen cannot account for the morphology-
governed adsorption on mNPs.
Following Van Vleck’s proposal [306] of spin–orbit coupling induced MCA, calcu-
lations of the magnetic anisotropy of metallic bulk phases and slabs have been carried
out at different levels of approximation, pioneered by Brooks [307], Fletcher [308], and
Daalderop [309,310], which have given satisfactory agreement with experimental methods.
An interesting phenomenon of spin reorientation in metallic 2D systems has been observed
for supported magnetic films (Fe/Ag(001) [311], Co/Au(111) [312], Ni/Cu(001) [313]). The
crucial parameter that affects the direction of magnetisation is the film thickness, as it can
induce change in the spontaneous magnetisation axis due to the competition between the
interface anisotropy and the effective bulk anisotropy, which includes magneto-crystalline
and shape anisotropy energies. It has been recently demonstrated that the electronic states
can be responsible for the oscillations of the magnetic anisotropy in Fe(001) thin films with
periods of five to nine monolayers since the quantum well states formed by d electrons
change position in reciprocal space depending on the magnetisation direction [314–316].
Magnetisation-dependent spin–orbit gaps were also observed when the system symmetry
was decreased compared to the bulk symmetry. Other factors influencing the interface or
bulk terms include temperature conditions (annealing [317]), the presence of surfactants
(capping layers [318,319]), and the stacking sequence [320], to name a few, and hence the
spin reorientation in the metallic systems also depends on each of these parameters.
The thickness dependence of the MCA energy of cobalt films for different slab arrange-
ments (hcp (0001), fcc (001), and fcc (111), built from the experimental lattice constants)
is shown on the left in Figure 9 at the local spin density approximation (LSDA) theory
level [321]. In the progression from ultrathin to >10 Å slabs, significant oscillations are
captured. For slabs with fewer than three atomic layers, interaction between the layers is
more pronounced, resulting in a less systematic behaviour that deviates from the general
trend. A certain degree of MCA energy convergence with respect to the slab thickness is
also obtained as the number of layers increases, although the oscillations comparable to
the total anisotropy values persist even for the thickest slabs considered. Cubic symmetry
imposes a minimal barrier for the transition between any of the perpendicular magneti-
sation directions since its calculated anisotropy is less than a few µeV, meaning that the
anisotropies of differently arranged fcc slabs are determined only by the in-plane lattice
structure, considering that the bulk anisotropy is negligible. Thus, the converged values
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are actually the surface anisotropy energies, and their estimations are −0.38 meV for the
(001) fcc surface and 0.19 meV for the (111) fcc surface. Note that a positive MCA energy
means that the easy magnetisation axis is out-of-plane, whereas a negative MCA energy
belongs to slabs with an in-plane easy magnetisation axis. The MCA energy of the hcp
(0001) slab shows a slightly negative slope, where the gradient of the linear fit for slabs
with more than 10 layers is −0.015 meV. This is in good agreement with the MCA energy
of the LSDA hcp bulk Co, which was calculated to be −0.010 meV. The value of the surface
anisotropy for the hcp (0001) surface has converged to 0.44 meV.
Figure 9. MCA energies for different fcc and hcp Co surfaces of varying thickness calculated at the
LSDA level of theory (left) and estimated shape anisotropy (right). Symbols are the same for both
graphs. Data are taken from Zhang (2009) [321]. Legends are the same for both graphs.
Another important contribution to the magnetic anisotropy of the system is the shape
anisotropy energy. For 2D films, shape anisotropy can be estimated at 2µBMs2, as shown
for Co slabs in Figure 9 on the right. For both fcc and hcp Co slabs, the shape anisotropy
energy has almost the same linear dependence with respect to the thickness.
Calculations based on the unrestricted GGA relaxation of the four-layer surface slab
models were conducted for comparison, as shown in Figure 9 on the left, and agreement in
the results is satisfactory. Predicted anisotropy energies for the (0001), (1011), and (111)
Co slabs are hence 81.4 µJ/m2 or 6.57 µeV/atom, −7.98 µJ/m2 or −0.70 µeV/atom, and
199.01 µJ/m2 or 16.63 µeV/atom, respectively. These MCA values arise from the same
computational setup that captured the correct order of magnitude for bulk MCA of hcp
and fcc cobalt (calculated at 4.16 × 105 J/m3 or 27.20 µeV/atom and −1.68 × 104 J/m3 or
−1.54 µeV/atom; experiment at 0 K 7–8 × 105 J/m3 or 65 µeV/atom and −2.36×104 J/m3
or −1.6 µeV/atom [322]). Results of other experimental and theoretical studies conducted
on self-standing Co films also showed varying values depending on the film thickness.
From the anisotropy modelling of close-packed (111) ultrathin transition-metal films, the
MAE obtained for the Co (111) film was −0.28 meV [323]. A Néel model of the Co (0001)
surface predicted an MAE of 84 µJ/m2 [324], whereas measurements on the 1000 Å thick
Co film resulted in an in-plane anisotropy volume of −7.2 × 102 J/m3 [325].
2D Co systems deposited on different substrates have received a lot of attention for their
unique magnetic properties, both experimentally [320,326,327] and theoretically [328–331].
For a nonmagnetic supporting material, such as a gold surface, measured MAE values
correspond well to those calculated for unsupported extended slab models—experimental
measurements on the Au/Co interface gave values of 53–70 µJ/m2 [332]. Another study
of the Co/Au(111) system showed 17 µeV/atom out-of-plane magnetic anisotropy [333].
Supported ultrathin Co films are characterised by much higher anisotropy values. When
ultrathin films of cobalt atoms were deposited on Rh(111) and Pt(111) surfaces, the MAE
values measured were −0.37 ± 0.05 and −0.29 meV per Co atom, respectively [334]. The
combination of Co and Ir in a three-layer system gave rise to a similar anisotropy of
0.46 meV per atom, whereas only 0.02 meV MAE per atom was calculated for the Fe–Co–Ir
system [335]. Furthermore, significant oscillations were observed in the interlayer exchange
coupling for systems of varying numbers of Co and 4d transition-metal series layers, and
the following quantitative trends of magnetic properties were formulated as a result: across
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the noble metals and Pd, a ferromagnetic interlayer coupling was found; for the post-noble
metals and most 4d transition metals (with the exception of Mo), an antiferromagnetic
interlayer coupling was obtained, meaning that the choice of the metal can influence
the easy axis of magnetisation [336]. The interface magnetic anisotropy of the Co (0001)
film was shown to increase by 36 µJ/m2 upon Co surface oxidation, and follow-up DFT
calculations correlated this change with a positive charge increase of 0.54e− per oxidised
Co atom [337]. However, the MAE of extended metal slab models is strictly dominated by
the surface anisotropy factor, whereas the three-dimensional shape anisotropy that often
affects both intensity and easy axis of MAE of mNPs cannot be accounted for through the
2D models.
3.1.3. Nanoparticle Model
A surface representation of mNPs deliberately neglects the role of undercoordinated
particle sites, namely edges and vertices, and the effect of the full mNP geometric and
electronic structure, which often differs from that of the bulk material. However, converged
surface energies obtained by employing surface slab models can be implemented to build
NP models using the well-known Wulff construction method [338–340]. The premise of
the Wulff construction is that the length of a vector drawn normal to a crystal face from
the particle centre is proportional to the surface energy of the corresponding facet, and
the crystal equilibrium shape is obtained through the necessary minimisation of the total
surface energy of the particle. In practice, there is an infinite number of possible surfaces
that can be included in the model. Restraining the surface exploration to a set of those that
are experimentally observed is a plausible strategy, whereas taking into consideration only
the surfaces with low indices, which in general tend to include the most stable members, is
a relatively reliable getaway because such surfaces are the most likely to be expressed in the
morphology. Wulff NP construction of low-index facets has become a standard technique
to build particle models, as shown in Figure 10. As the contributions from the particle
edges are neglected in the Wulff construction method, the shape of small particles might
deviate from the predictions, but experimental analysis indicates that particles in the range
of a few nanometres are generally consistent with this construction principle [341,342].
Figure 10. Illustration of the Wulff construction of an fcc particle. Growth direction of crystal facet
planes is represented by black arrows, and the centre of the particle is represented by a black dot.
Atoms enclosed in the equilibrium shape of the nanoparticle are coloured in teal, while the rest of the
bulk atoms are grey. 3D morphology is shown in wire-frame and atomic representation.
More compact, quasispherical NP shapes can be constructed by applying symmetry
operations over stable surface members to obtain the highest density of atoms within
the NP volume, resulting in the multiple-twinned particle models. These are known
as noncrystalline NP models, and the most common is the icosahedron composed of
20 tetrahedra with (111) close-packed facets as their base and the central vertex as their
apex, conjoined at 12 boundary vertices with a fivefold rotational axis, as initially proposed
by Mackay [343]. The decahedron, on the other hand, is formed of five tetrahedra with
(111) close-packed facets, but its sphericity is far from that of the icosahedron, and it
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was first suggested by Ino [344]. Vertex and edge truncations, suggested by Marks and
Ino [345,346], can be implemented to achieve a better surface-to-volume ratio. However,
any noncrystalline motif is obtained at the expense of volume contributions for facets to be
able to close the intersurface gaps. Some of the possible mNP models, both crystalline and
noncrystalline, are represented in Figure 11.
Figure 11. Models of crystalline NPs (left to right: fcc—cuboctahedron and truncated octahedron,
bcc, and hcp) in top panel and noncrystalline NPs (left to right: icosahedron, regular, Marks, and Ino
decahedron) in bottom panel.
Significant progress in the modelling of mNPs was made when moderately large
NP models were implemented in DFT calculations for the simultaneous description of
terrace sites of extended surfaces and low-coordinated edge and vertex sites. The NP
model strategy is sufficient in providing the influence of the particle size and shape on
the properties of interest by defining the so-called scalable regime where many properties
(typically nonlocal—independent on the position of different atoms within the cluster, such
as cohesive energy per atom) monotonously converge toward the bulk or extended surface
limit. Other, more localised properties, which are related to the atoms of a particular region
of the NP, such as adsorption energies of simple adsorbates, show invariance with respect
to the number of atoms and slowly converge with the increase in the NP size.
Monotonous convergence of the cohesive energy of Co mNPs by applying the NP
model is shown in Figure 12 (left) for various morphologies and particle sizes [239]. To
limit the exhaustive number of calculations that would be needed if every NP size was
considered, the choice of sizes of interest is usually driven by the well-known oft-recurrence
of mNPs with a complete, regular outer geometry, designated as full-shell NPs. These
numbers, known as magic numbers, are obtained through the mathematical relationships
determined individually for each structural motif [347,348].
Size and morphology dependency of the energetic stability of a Co mNP is well
represented by linear regression and can be extrapolated to very large mNP sizes. For sizes
below 100 atoms, the stability of motifs based on the successive increase in the cohesive
energy per atom decreases going from the most stable icosahedron, over fcc truncated
octahedron, hcp, fcc cuboctahedron, and decahedron, to bcc as the least stable shape of Co
mNPs. Differences in energies for the clusters with the same number of atoms between any
two shapes are close to or less than 0.10 eV per atom. The icosahedron is identified as the
most stable shape throughout the whole range of small and medium cluster sizes, consistent
with the experimentally determined predominance of this noncrystalline shape within
particles of up to N = 800 atoms [349,350]. The icosahedron-to-hcp transition is predicted
to happen at around N ≈ 5500. An enlarged view of the intersection is represented as an
insert in Figure 12 (left).
A linear fitting approach based on the magic-numbered mNPs and a subsequent de-
termination of the stability trends is constrained by the assumption that the stability order
is maintained for the remaining, nonmagic particle sizes. Based on the experimental indica-
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tions of the simultaneous occurrence of more than a single geometrical shape at practically
any size, linearly interpolated morphology transitions of magic-numbered clusters serve
only as a guideline to the predominating geometry. A promising qualitative agreement was
found in recent works that have conducted a full sampling of the energy landscape beyond
the magic numbers, where the dominant mNP shape coincides with the one predicted by
a ‘simple’ magic number linear fit [351–353]. The noncrystalline/crystalline distributions
thus obtained for Co clusters with magic numbers of atoms represent a good reference point
for defining crossover sizes between the structural motifs. Note that shape alternations
could occur in reported stability windows, but they should nevertheless be expected to
contain the highest proportion of the energetically most favourable structure.
Figure 12. Linear fitting of the cohesive energies of Co NPs of varying morphologies with
55 < N < 1500 atoms with an insert capturing the crossover between the icosahedral and hexagonal
shape (left) [239]. Progression of oxygen adsorption energies from nonscalable (2 < N < 50) to scalable
regime of Co NPs with hexagonal symmetry (right); extended slab models are denoted as ∞.
An example of the convergence of more localised properties is the size-dependent
progression of the adsorption energy. Calculations of the adsorption behaviour of simple
adsorbates, but also of more complex molecules, have captured the nonscalable regime of
the smallest metallic cluster models and convergence of adsorption energies for particles
composed of approximately 50–60 atoms [273,354–361]. Size dependence of oxygen adsorp-
tion on small Co clusters with hexagonal symmetry and large crystalline hcp NP models,





in the hcp mNP morphologies, is depicted in Figure 12 (right) [362]. The 13-atom hcp Co
cluster shows by far the most favoured oxygen adsorption, followed by notable oscillations
in the adsorption strength established for succeeding cluster sizes. A nonscalable regime
extends to the Co clusters with 30 < N < 50 atoms, similar to what was observed for other
metallic systems. For particles with more than 30 atoms, distinctive facet areas can be




hcp Co surfaces, with each showing unique adsorption
behaviour based on their structural arrangements. Nevertheless, adsorption interaction
on both constituent hcp mNP surfaces eventually converges to the respective extended
slab adsorption energies. The difference in adsorption strengths on the large 323-atom hcp
mNPs is insignificant compared to the periodic slab models.
The emergence of the scalable regime occurs at different cluster/NP sizes for distinct
properties. The density of states, and, accordingly, the electronic structure, evolves rapidly
towards bulk-like behaviour, which enables the use of relatively small mNP models for
evaluating the chemical activity of sites characterised by low coordination numbers. The
activity toward the adsorption of atomic or molecular species is often evaluated using
either the d-band centre as the electronic descriptor or the generalised coordination number
as the geometric descriptor, since it was found that the two are linearly correlated [363].
As a general convergence rule, properties are essentially considered converged when
the local atomic environment is maintained with the further addition of atoms. For example,
the adsorption strength is mostly conditioned by the adsorption site, followed to a substan-
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tially decreased extent by the influence of the first atomic neighbours and the second-shell
neighbours, whereas neighbours of the third shell have negligible contributions. This
approach can be extended to other local or regional properties.
To obtain an optimal description of the mNP properties of interest, it is crucial to
choose the particle size that will reliably capture the effects of the studied morphology
without accentuating either cluster-dominated behaviour or the monotonicity of the ex-
tended slab perspective. This is especially important when investigating the magnetic
properties, because they are easily influenced by symmetry factors, directional interactions,
and local atomic environment.
Figure 13 represents the core-to-shell progression of magnetic moments in differently
sized icosahedral and hcp mNPs. The 13-atom cluster size from the nonscalable regime
clearly stands out for both core and shell segments. For larger mNPs, core and inner-most
layers show 15–25% lower magnetic moments compared to the surface itself or to the layers
in close proximity to the surface. The increase in the magnetisation of surface atoms is
hence 3 to 5 times more pronounced than in the case of extended slab models. Additionally,
some distinctions in the overall core-to-shell trends have also been captured compared to
the layer-to-layer progression of extended slab models.
Figure 13. Magnetic moment per Co atom, µ, as a function of the Co NP layers for increasing
nanoparticle size—left: icosahedral NPs, right: hcp NPs. Layers are numbered going from the core
to the shell of the NP.
These differences become more pronounced when the effects of oxidation on the
magnetic moments are examined for 147-atom icosahedron and 153-atom hcp Co mNP
models (Figure 14). Compact organisation of Co atoms within the mNP morphologies
allows for less flexible rearrangement to accommodate atomic adsorbates such as oxygen
into the structure, in contrast to the frequently observed adsorption-induced reconstruction
of the top-most layers of a surface slab [364–370]. For this reason, enhancement of the
magnetic moments of the layer placed immediately below the vacuum-exposed outer shell
obtained upon oxidation is significantly modified in the absence of surface rearrangement.
The increase in the average magnetic moments for Co atoms within this layer is about 8%





surfaces are 30–40%. The increase in the surface shell magnetic moments
is 11–20%. Additionally, elongation of the inner Co–Co distances upon the interaction of
surface Co atoms with oxygen adsorbates lessened the volumetric strain and consequently
the quenching of the magnetic moment of the central atom. This adsorbate-induced effect
could not be captured within extended slab models.
The morphological dependence of the magnetic properties of Co mNPs is captured
in Figure 15. Respectable shape deviation of magnetic moment per Co atom is observed
only for the smallest mNPs, where each morphology has a unique share of vertex and
edge sites. These differences wear off with the increase in the mNP size, when average
magnetic moments start rapidly converging towards the bulk Co value. The MAE of mNPs,
on the other hand, depends strongly on the shape anisotropy arising from the varying
morphologies for all mNP sizes. This is a specific aspect of magnetic nanoparticles, and it
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is impossible to capture it within the extended slab models. The computational expense of
noncollinear DFT calculations limited the determination of MAE to particles with 1–2 nm
diameters (50–200 atoms), and the results obtained are shown in Figure 15 (right), together
with the experimental data measured for embedded Co mNPs [371].
Figure 14. Structures of oxidised 147-atom icosahedron and 153-atom hcp Co mNPs (left) and
corresponding layer-averaged magnetic moments per Co atom with core-to-surface progression,





facets are also given.
DFT results indicate that the Co mNPs with hexagonal symmetry have the highest
MAE values of 1412.5 kJ/m3 for 0.8 nm and 397.9 kJ/m3 for 1.3 nm diameter mNPs.
Calculated MAE for the 1.5 nm decahedron is 398.2 kJ/m3, whereas the other noncrystalline
icosahedron shape is characterised by very low anisotropies, 30.2 and 65.6 kJ/m3 for 1.0
and 1.5 nm mNPs, respectively. MAEs of 0.7, 1.0, and 1.4 nm fcc truncated octahedra from
DFT calculations are 439.9, 218.0, and 194.5 kJ/m3 and correspond well to the experimental
anisotropy trend. Experimental data have been complemented by the Néel pair modelling
to correlate the observed MAE features to the increased importance of the exposed facets,
namely those of the (100) and (111) fcc Co surfaces, which is also shown in Figure 15 (right).
The addition of a single facet does not contribute significantly to the modifications in the
shape, but it is sufficient to break the symmetry and induce a change in the anisotropy
of the entire particle. Such increase in the surface area successfully reproduced both
experimentally observed effects, the increased MAE values with respect to the bulk for the
smallest sizes and the varying trend in MAE with decreasing size. However, even though
the addition of a single facet decreases the general enhancement in magnetic anisotropy for
larger particles, it is nevertheless possible to obtain very large MAE values because of the
shape-induced anisotropy. This means that notably polycrystallinity, which is expected in
large particles due to the fabrication mechanism, plays an important role in reducing the
contributions of crystal symmetry-breaking to the global anisotropy. Defects have, on the
other hand, been proposed as responsible for uniaxial anisotropy in larger cobalt or iron
mNPs (8–20 nm) [372,373].
Other experimentally measured MAE energies are reported in the range of 6.0–30.0 kJ/m3,
consistently above the Co bulk values (2.7 kJ/m3 fcc and 4.4 kJ/m3 hcp) [374–376]. Geo-
metrical shapes of the particles are not always provided in these studies, but it is suspected
that they are mostly crystalline fcc or icosahedral Co mNPs. Moreover, several studies of
various mNPs and for different sizes have observed the coexistence of crystallographic
structures both in the gas phase and deposited [377–380], especially without further an-
nealing. Comparable strong variations with values of the same order (between 10 and
400 kJ/m3) have been derived for icosahedral Co mNPs in the 3.1–4.3 nm size range [381].
As hexagonal structures in Co mNPs are expected to compete in stability only at larger
sizes above 20 nm [239,382], crystalline structures of fcc features are naturally dominant in
any size range up to this critical size, and the general trend obtained in the experiments
cannot be specifically assigned to the exact crystalline structure. For a specific case of
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3.0 nm truncated octahedral particles, experimentally derived anisotropy constants are in
the range of 10–200 kJ/m3 [383].
A combination of DFT simulations and NP models is hence a very powerful tool in
predicting the magnetic behaviour of mNPs, and it corresponds very well to the complexity
of the size- and morphology-dependence problem. With improvements in computational
power and performance, it has become possible to utilise the advantages of the NP models
over couple-atom clusters and extended slabs and to capture reliable values of magnetic
moments, anisotropy energies, and adsorbate-induced alternations in the magnetic be-
haviour of mNPs [384]. These advances are expected to facilitate the research on mNPs with
favourable properties for MRI contrast and magnetic nanoparticle hyperthermia agents.
Figure 15. DFT-predicted progression of average magnetic moment per atom, µ, (left) and compari-
son between DFT-calculated, experimentally measured, and Néel pair surface correlated magnetic
anisotropy energies, MAE, (right) with the increase in the size for Co mNPs of varying morphologies.
DFT results are taken from Farkaš (2021) [384], and experimental and Néel pair modelling results are
taken from Oyarzún (2005) [371].
3.2. Protected mNPs: Ligand Effects on Magnetic Properties
Two main features dominate the magnetic properties of mNPs: (1) their physical
appearance, i.e., size and morphology, and (2) surface effects, i.e., symmetry breaking of
the crystal structure at the mNP surface, canted spins of surface atoms, surface oxidation,
or chemical effects induced by the bonding of surfactant molecules.
Since gas-phase mNPs have limited stability and can only exist on the order of a
few milliseconds, their use in new technologies is based on more practical systems whose
longevity is provided through the stabilisation by surface functionalisation [385–387]. Func-
tionalisation molecules also passivate the mNP by forming bonds with the reactive surface
metal atoms directly exposed to the environment. Unfortunately, the attachment of surfac-
tants is notoriously correlated with the quenching of mNP magnetic moments [388–391].
In general, the extent of ligand-induced changes in magnetic behaviour depends on the
metal–ligand pair in question. The origin of magnetic moment quenching of respective
metal atoms in metal–ligand complexes has been linked to two electronic parameters:
changes in the d-electron count of the metal and changes in the energy level splitting of the
metal d orbitals through a ligand field effect [392–394]. These ligand-induced changes are
indications of the possibly strong ligand effects on magnetic properties of mNPs where
ligand-induced changes could scale as a function of the mNP size.
Ligand effects have been recognised as important factors in the implementation of
mNPs in biomedicine, since functionalisation often comes at a cost of not only reduced
magnetisation, but also changed surface anisotropy. It has been recently demonstrated that
the deposition of a self-assembled monolayer of alkanethiolates on an ultrathin Co film
grown on Au(111) induces a spin reorientation transition from in-plane to out-of-plane
magnetisation, changing the anisotropy values [333]. Computer simulations of these issues
have often relied on the representation of mNPs as extended slab models because of the
cost of noncollinear calculations. However, this approach causes even more uncertainties
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when estimating ligand-induced changes in magnetisation than in the simple assessment
of the adsorption reactivity, because the neighbouring shells of atoms play a minimal role
in the adsorption strength, while their contribution to the global magnetic behaviour is
much more prominent.
To make a connection between the impact of ligands on the emergent properties of
coordination complexes and in larger ligand-functionalised metallic structures, systematic
studies of a combination of varying Co mNP size and a series of ligand shell compositions
have been conducted.
Figure 16 shows the linear-like relationship between the total magnetic moment
and the Bader charge on the Co core for different ligand shells and two core sizes, a
13-atom Co cluster and a 55-atom Co mNP. In general, there is a net quenching of the total
magnetic moment relative to the bare cluster for each system, due to spins being paired in
surface–ligand bonds. However, as the charge on the core becomes more positive, the total
magnetisation increases. The intensity of the quenching is preserved with the increase in
the particle size [395].
Figure 16. Total magnetic moment as a function of Bader charge for varying ligand shell composition
on 13-atom (left) and 55-atom (right) icosahedral Co mNPs. Dotted lines indicate values of the bare
mNPs. Data are taken from Hartmann (2016) [395].
The average local magnetic moments of each Co atom were found to span a wide
range of values as a function of the ligand shell composition [396]. The 13-atom cluster-PH3
ligand system quenches magnetic moments of all Co atoms from the bulk value of 1.72
to 1.61 µB, whereas a fluorine ligand shell results in an increased atomic Co magnetic
moment of 2.39 µB. The 55-atom mNP–PH3 analogue experiences similar local magnetic
moment quenching, even at the mNP centre. The 55-atom mNP–chlorine system also
follows the trends of the chlorine-functionalised 13-atom cluster, with the chlorine ligands
localising charge and increasing the magnetic moments of surface Co atoms. Analysis of
bond lengths and surface–ligand bond angles showed that these alternations in atomic
magnetic moments are not driven by geometry modifications due to functionalisation,
but depend only on the type of ligand. This provides continuity in the locally induced
magnetisation changes over differently sized metallic cores.
The transferability between the core size and magnetic moments of protected Co mNPs
was confirmed through investigations of biomedically relevant ligands, namely carboxylic
acids. Considering the scaling of ligand-induced changes in the magnetisation as a function
of the Co NP size, half and full monolayer coverages of acetic acid have been modelled by
DFT with the aim of identifying general trends. Progression of ligand-induced changes in
the magnetic moments within the centre, inner, and surface segments of icosahedral Co
mNPs with varying sizes (N = 13, 55, 147) upon carboxylic acid functionalisation is shown
in Figure 17. Changes in the magnetisation of 55- and 147-atom Co mNPs with the increase
in the density of the ligand shell correspond very well for each segment of the two mNP
sizes, indicating that the smaller NP model is sufficient to capture the magnetic behaviour
of protected Co mNPs.
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Figure 17. Ligand-induced changes in the magnetic moments of centre, inner, and surface segments
of the 13-, 55-, and 147-atom icosahedron Co mNPs functionalised by a half and full acetic acid
coating. ∆µ is the difference between the average magnetic moment of each segment in unprotected
and protected mNPs.
To gain more detailed insight into the coverage-dependent changes in the magnetic
properties, average magnetic moments per Co atom are given as a function of the percent
ligand coverage for Cl-, PH3-, and COOH-protected Co mNPs in Figure 18. In the case
of each ligand type, there is a strong correlation between ligand coverage and resulting
magnetic moment per Co atom, yielding a linear trend as was the case for the total magnetic
moments as a function of the core charge. However, different ligand binding types can lead
to both an increase and a decrease in the average magnetic moment of varying intensities
compared to the moments of the unprotected mNPs. Higher Cl coverage has an enhancing
effect on the atomic magnetic moments, where the line of best fit indicates a 0.0043 µB
increase per percent coverage. However, an increasing magnetic moment arising from the
passivating shell composed of acetic acid molecules shows a significantly slower growth
of 0.0009 µB per percent coverage. In contrast, a PH3 shell leads to the quenching of the
average atomic magnetic moment by 0.0065 µB per percent coverage. Taken together,
the deviations in average atomic magnetic moment as a function of ligand identity and
coverage are evidence that the composition and density of the passivating shell have a
stronger impact on magnetisation than the size of the Co core.
Figure 18. Average magnetic moment per Co atom, µ, as a function of ligand coverage for icosahedron
Co mNPs passivated with Cl and PH3 (left) and COOH (right). Average magnetic moment per Co
atom for unpassivated 55-atom Co icosahedron is added as the dotted line. Data on the left are taken
from Hartmann (2018) [396], and data on the right are taken from Farkaš (2021) [384].
To capture ligand effects on the mNP anisotropy, ligand-protected icosahedron Co
mNPs with varying coverages of biomedically relevant ligands (carboxylic acid, thiol,
amine) were modelled. The calculated anisotropy energies are shown as a function of
coverage in Figure 19. Starting from a very low value of 30.2 kJ/m3 for the unprotected
55-atom Co icosahedron, all three ligand families enhance the MAE with an increase in
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the coverage density. The rates of this increase are, however, ligand-dependent. Amine
passivation resulted in the lowest enhancement of MAE, calculated for a 100% coverage
at 531.4 kJ/m3. A change in the direction of the easy axis of magnetisation was also
captured for amine-protected mNPs with coverage densities between 60 and 70%. There
is a steady increase in the MAE of acid- and thiol-passivated Co mNPs as the protective
coatings become denser, with acidic ligands showing a slightly higher enhancement rate
per percent coverage. However, for the maximum coverages of 90 and 100%, MAEs of
both acid- and thiol-protected Co mNPs reach similar energies with values between 987.0
and 1087.0 kJ/m3.
Figure 19. Structures (left) and magnetic anisotropy energy, MAE, as a function of ligand coverage
(right) of COOH-, NH2-, and SH-passivated 55-atom icosahedron Co mNPs. MAE of unpassivated
55-atom Co icosahedron is added as the dotted line. Data are taken from Farkaš (2021) [384].
Overall, ligand binding induces local changes on the atoms of Co cluster and mNP
systems, analogous to the effects in the ligand field theory. However, because the local
coordination site is a component of a larger nanocluster, the impact of each ligand is
observed beyond the metal centre to which it is directly bound. Furthermore, the chemical
identity of the ligand within each binding motif provides a fine-tuning mechanism on the
exhibited magnetic behaviour through the connection between the electronegativity of the
functional group and the amount of electron density withdrawn from the core. Finally, as
the size of the mNP increases, ligand-dependent magnetic properties persist, although they
are slightly dampened.
3.3. Alloyed mNPs: Effects of Interfaces on Magnetic Properties
The applicability of single-component mNPs is restricted by limited property-tuning
possibilities. To overcome this limitation, mNPs can be modified through the construction
of bimetallic architectures consisting of two distinct metals, one or both of which should
be magnetic [397–402]. Bimetallic (and multimetallic) mNPs, often referred to as magnetic
nanoalloys, present properties with a very high degree of tunability owing to the variety of
morphologies they can adopt. Their morphology is specified not only by the geometric
structure, as in the case of the monometallic systems, but also by the chemical ordering of
its components, which corresponds to the arrangement of the two metallic phases within
the specified geometry.
The expectations of improved magnetic properties of monometallic mNPs by incor-
porating additional metallic phases originated from the very large magneto-crystalline
anisotropy of the respective bulk and thin-film alloyed materials [403–408]. DFT calcu-
lations were shown to be capable of quantitatively describing the MAE and the orbital
magnetisation in these alloys [409–412]. For example, in the case of the L10 CoPt crys-
tal, DFT predicted an MAE of 4290 kJ/m3 [227], very close to the experimental value of
4000 kJ/m3 measured by Eurin [413] and much higher than that of the fcc or even hcp Co
bulk (23.6 and 700–800 kJ/m3).
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Nevertheless, it was observed that the magnetic properties of alloyed mNPs could be-
come worse than those of bulk metals, in contrast to the monometallic mNPs. The magnetic
anisotropy energy of L10 CoPt NPs was found to be 385 kJ/m3 [414] or 1700 kJ/m3 [415],
both values much smaller than that measured for the bulk L10 CoPt crystal. Moreover,
a clear reduction in the saturation magnetisation of CoPt mNPs was captured with a de-
crease in the particle size [416]. Bimetallic mNPs are still promising for many applications
because, despite the deterioration in the magnetic behaviour with respect to bulk alloys,
which was suggested to be caused by surface effects (surface adsorption and surface spin
canting [417]), their anisotropies and magnetic moments substantially exceed those of the
monometallic counterparts. For example, distinct L10 orderings in CoPt mNP systems
have already shown how improved MAE can translate into superior catalytic performance
in fuel cells [418].
The central difficulty in predicting magnetic properties of bimetallic mNPs lies in
the complexity of the possible combinations in composition, geometry, and chemical
ordering. Compared to the intermixed L10 state of CoPt NPs, surface-segregated cuboidal
counterparts have shown magnetic moments reduced by 0.52 µB and a 19% decrease in
MAE. More pronounced, when the cuboctahedral morphology was considered, reductions
in the total magnetic moment and CoPt mNP anisotropy were of the order of 4.96 µB and
45%, respectively [227].
Finding the optimal bimetallic mNP morphology for a specific composition of two
metallic phases by employing MD simulations has shown good agreement with proposed
structures of experimentally synthesised systems [419–425]. Owing to the difficulties
in assigning magnetic properties to a specific mNP morphology through experimental
techniques, DFT simulations are also valuable in predicting the magnetic behaviour of
bimetallic mNPs of varying geometries and chemical orderings.
As to their thermodynamic stability, the cuboctahedral shape with L10 crystal or-
der was obtained as the most stable geometric structure for large CoPt NPs, based on
the DFT-calculated surface energies and Wulff construction theorem [426]. Specifically
for CoPt mNPs with diameters below 2.5 nm, DFT calculations have directly predicted
the multiply twinned icosahedral and decahedral mNPs to be more stable than the L10
cuboctahedron [238].
For biomedical applications, the alloying of cobalt with more inert metals such as
silver or gold has proved to be a valuable strategy to obtain biocompatibility and reduce
oxidation. In accordance with the large differences in atomic radii in favour of inert metals,
and weak Ag–Co/Au–Co miscibility predicted below 400 ◦C across all compositional
space [427], theoretical studies have reported structures that favour Ag/Au surface seg-
regation and the formation of core–shell orderings [402,428,429]. Experimental synthesis
has confirmed theoretical predictions, and core–shell AuCo mNPs were found to have
mostly icosahedral structure, although a novel morphology has been recently described
consisting of a Co icosahedron surrounded by fcc Au facets [430–432]. In addition, reports
have indicated that optical and magnetic properties may both be tuned by tailoring the
size of the core and shell of Ag/AuCo mNPs. However, the fact that the surface of the
nanoalloy is expected to contain mostly Au (or other noble and inert metals such as Ag or
Pt) atoms does not invariably determine the chemical ordering of such systems. The size,
structure, and chemical arrangement of bimetallic mNPs can be controlled experimentally
throughout the synthesis protocol, allowing metal species to intermix and maximise the
synergistic benefits available through their unique combination. For example, physical
methods have been reported for the synthesis of AgNi disordered mNPs, which exhibited
substantial enhancement in their optical limiting efficiency [433]. Core–shell AuNi NPs
with inverted segregation (Au cores covered by Ni) have shown huge magnetisation, which
was maintained even after the formation of NiO on the surface [434]. The hybrid AuCo
systems are consequently also expected to offer unique properties in different chemical
orderings because of the possible magnetoresistance effect and optical–magnetic bifunction-
alities [435]. Although the limited literature on AuCo systems is almost exclusively focused
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on the core–shell structures, Marbella et al. have demonstrated the synthesis of discrete,
composition-tuneable alloyed AuCo NPs with random ordering of Au and Co atoms,
whose magnetic susceptibility can be tailored while maintaining almost identical particle
size and surface chemistry [54]. Finally, a theoretical study has shown that magnetic effects
can destabilise core–shell arrangement of AgCo and AuCo systems whose icosahedral
structures remain preferential, but peculiar quantum effects reverse the energetics in favour
of intermediate compositions, presenting a much more thorough intermixing with cobalt
atoms [33].
The magnetic anisotropy of AuCo mNPs was calculated to be an order of magnitude
higher for L10 ordering compared to the core–shell NPs of 1.5–2.0 nm in diameter. Predicted
MAE values for cuboctahedron, icosahedron, and decahedron with the L10 ordering were
928.3, 1038.3, and 1011.7 kJ/m3, respectively. A corresponding core–shell icosahedron
showed MAE of 239.9 kJ/m3, while the MAE of a decahedron with core–shell structure was
found to be 278.2 kJ/m3. Hence, L10 bimetallic AuCo mNPs show a 15-fold improvement
from the anisotropy of a 1.5 nm monometallic Co icosahedron, which will hopefully trigger
improved efforts in the synthesis of these systems and their use in biomedical applications.
4. Conclusions
With the advances in computational power and continuous improvements of DFT
methods, the implementation of explicit NP models in simulations of nanoparticle systems
should be encouraged, since they are a more realistic representation and able to capture the
property dependence on size and morphology. Whilst cluster and extended slab models
can often offer valuable insight into the nature of metal–adsorbate interaction, they fail to
capture the progression and directional effects of magnetic properties.
DFT simulations of NP models have shown excellent correspondence with experi-
mental measurements of magnetic moments and magnetic anisotropy energies of cobalt
mNPs. They are able to properly describe morphology-induced alternations in the mag-
netic features, calculate ligand effects on both the binding metal centre and the particle as a
whole, and predict the outcomes of alloy interfaces of different chemical orderings. It is
thus expected that ab initio methods can also provide accurate structures and properties of
magnetic mono- and bimetallic NPs that do not necessarily have cobalt in their composition.
Incorporation of NP models in research efforts to optimise the magnetic behaviour
of metallic magnetic nanosystems for biomedical applications could hence facilitate the
smarter design of application-specific properties.
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233. Safaltın, Ş.; Gürmen, S. Molecular dynamics simulation of size, temperature, heating and cooling rates on structural formation of
Ag-Cu-Ni ternary nanoparticles (Ag34-Cu33-Ni33). Comput. Mater. Sci. 2020, 183, 109842. [CrossRef]
234. Han, Y.; Jiang, D.; Zhang, J.; Li, W.; Gan, Z.; Gu, J. Development, applications and challenges of ReaxFF reactive force field in
molecular simulations. Front. Chem. Sci. Eng. 2016, 10, 16–38. [CrossRef]
235. Deeth, R.J.; Anastasi, A.; Diedrich, C.; Randell, K. Molecular modelling for transition metal complexes: Dealing with d-electron
effects. Coord. Chem. Rev. 2009, 253, 795–816. [CrossRef]
236. Fracchia, F.; Del Frate, G.; Mancini, G.; Rocchia, W.; Barone, V. Force Field Parametrization of Metal Ions from Statistical Learning
Techniques. J. Chem. Theory Comput. 2018, 14, 255–273. [CrossRef]
237. Dasetty, S.; Meza-Morales, P.J.; Getman, R.B.; Sarupria, S. Simulations of interfacial processes: Recent advances in force field
development. Curr. Opin. Chem. Eng. 2019, 23, 138–145. [CrossRef]
238. Entel, P.; Gruner, M.E. Large-scale ab initio simulations of binary transition metal clusters for storage media materials. J. Phys.
Condens. Matter 2009, 21, 064228. [CrossRef]
239. Farkaš, B.; de Leeuw, N.H. Towards a morphology of cobalt nanoparticles: Size and strain effects. Nanotechnology 2020, 31, 195711.
[CrossRef]
240. Souto-Casares, J.; Sakurai, M.; Chelikowsky, J.R. Structural and magnetic properties of large cobalt clusters. Phys. Rev. B 2016,
93, 174418. [CrossRef]
241. Fernando, A.; Weerawardene, K.L.D.M.; Karimova, N.V.; Aikens, C.M. Quantum Mechanical Studies of Large Metal, Metal Oxide,
and Metal Chalcogenide Nanoparticles and Clusters. Chem. Rev. 2015, 115, 6112–6216. [CrossRef]
242. Mark, L.O.; Zhu, C.; Medlin, J.W.; Heinz, H. Understanding the Surface Reactivity of Ligand-Protected Metal Nanoparticles for
Biomass Upgrading. ACS Catal. 2020, 10, 5462–5474. [CrossRef]
243. de Morais, R.F.; Kerber, T.; Calle-Vallejo, F.; Sautet, P.; Loffreda, D. Capturing Solvation Effects at a Liquid/Nanoparticle Interface
by Ab Initio Molecular Dynamics: Pt201 Immersed in Water. Small 2016, 12, 5312–5319. [CrossRef]
244. Kaddi, C.D.; Phan, J.H.; Wang, M.D. Computational nanomedicine: Modeling of nanoparticle-mediated hyperthermal cancer
therapy. Nanomedicine 2013, 8, 1323–1333. [CrossRef]
245. Nabil, M.; Decuzzi, P.; Zunino, P. Modelling mass and heat transfer in nano-based cancer hyperthermia. R. Soc. Open Sci. 2015,
2, 150447. [CrossRef]
246. Ng, E.Y.K.; Kumar, S.D. Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia
through Néelian and Brownian relaxation: A review. Biomed. Eng. Online 2017, 16, 36. [CrossRef]
247. Muscas, G.; Trohidou, K.N.; Peddis, D.; Vasilakaki, M.; Yaacoub, N.; Ntallis, N. Optimising the magnetic performance of Co
ferrite nanoparticles via organic ligand capping. Nanoscale 2018, 10, 21244–21253. [CrossRef]
248. Andreu, I.; Natividad, E. Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic
hyperthermia. Int. J. Hyperth. 2013, 29, 739–751. [CrossRef]
Materials 2021, 14, 3611 44 of 50
249. Michalakis, J.; Georgatos, S.D.; De Bree, E.; Polioudaki, H.; Romanos, J.; Georgoulias, V.; Tsiftsis, D.D.; Theodoropoulos, P.A.
Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition
of cell proliferation and cell death in vitro. Ann. Surg. Oncol. 2007, 14, 1220–1228. [CrossRef]
250. Yang, K.L.; Huang, C.C.; Chi, M.S.; Chiang, H.C.; Wang, Y.S.; Hsia, C.C.; Andocs, G.; Wang, H.E.; Chi, K.H. In vitro comparison of
conventional hyperthermia and modulated electro-hyperthermia. Oncotarget 2016, 7, 84082–84092. [CrossRef]
251. Mohamed, F.; Stuart, O.A.; Glehen, O.; Urano, M.; Sugarbaker, P.H. Docetaxel and hyperthermia: Factors that modify thermal
enhancement. J. Surg. Oncol. 2004, 88, 14–20. [CrossRef]
252. Rives, S.; Catherinot, A.; Dumas-Bouchiat, F.; Champeaux, C.; Videcoq, A.; Ferrando, R. Growth of Co isolated clusters in the gas
phase: Experiment and molecular dynamics simulations. Phys. Rev. B Condens. Matter Mater. Phys. 2008, 77, 085407. [CrossRef]
253. Rodríguez-López, J.L.; Aguilera-Granja, F.; Michaelian, K.; Vega, A. Structure and magnetism of cobalt clusters. Phys. Rev. B
Condens. Matter Mater. Phys. 2003, 67, 174413. [CrossRef]
254. Datta, S.; Kabir, M.; Ganguly, S.; Sanyal, B.; Saha-Dasgupta, T.; Mookerjee, A. Structure, bonding, and magnetism of cobalt
clusters from first-principles calculations. Phys. Rev. B Condens. Matter Mater. Phys. 2007, 76, 014429. [CrossRef]
255. Harada, M.; Dexpert, H. Electronic structure of transition metal clusters from density functional theory. 1. Transition metal
dimers. J. Phys. Chem. 1996, 100, 565–572. [CrossRef]
256. Reddy, B.V.; Nayak, S.K.; Khanna, S.N.; Rao, B.K.; Jena, P. Physics of nickel clusters. 2. Electronic structure and magnetic
properties. J. Phys. Chem. A 1998, 102, 1748–1759. [CrossRef]
257. Derosa, P.A.; Seminario, J.M.; Balbuena, P.B. Properties of small bimetallic Ni-Cu clusters. J. Phys. Chem. A 2001, 105, 7917–7925.
[CrossRef]
258. Jain, P.K. A DFT-based study of the low-energy electronic structures and properties of small gold clusters. Struct. Chem. 2005, 16,
421–426. [CrossRef]
259. Efremenko, I.; Sheintuch, M. DFT study of small bimetallic palladium-copper clusters. Chem. Phys. Lett. 2005, 401, 232–240.
[CrossRef]
260. Ma, Q.M.; Xie, Z.; Wang, J.; Liu, Y.; Li, Y.C. Structures, binding energies and magnetic moments of small iron clusters: A study
based on all-electron DFT. Solid State Commun. 2007, 142, 114–119. [CrossRef]
261. Zanti, G.; Peeters, D. DFT study of small palladium clusters Pdn and their interaction with a CO ligand (n = 1-9). Eur. J. Inorg.
Chem. 2009, 3904–3911. [CrossRef]
262. Katakuse, I.; Ichihara, T.; Fujita, Y.; Matsuo, T.; Sakurai, T.; Matsuda, H. Mass distributions of copper, silver and gold clusters and
electronic shell structure. Int. J. Mass Spectrom. Ion Process. 1985, 67, 229–236. [CrossRef]
263. de Heer, W.A.; Knight, W.D.; Chou, M.Y.; Cohen, M.L. Electronic Shell Structure and Metal Clusters. Solid State Phys. Adv.
Res. Appl. 1987, 40, 93–181. [CrossRef]
264. Martin, T.P.; Bergmann, T.; Göhlich, H.; Lange, T. Shell structure of clusters. J. Phys. Chem. 1991, 95, 6421–6429. [CrossRef]
265. Jena, P.; Castleman, A.W. Clusters: A bridge across the disciplines of physics and chemistry. Proc. Natl. Acad. Sci. USA 2006, 103,
10560–10569. [CrossRef]
266. Martins, M.; Wurth, W. Magnetic properties of supported metal atoms and clusters. J. Phys. Condens. Matter 2016, 28, 503002.
[CrossRef]
267. Zamudio-Bayer, V.; Hirsch, K.; Langenberg, A.; Ławicki, A.; Terasaki, A.; Von Issendorff, B.; Lau, J.T. Large orbital magnetic
moments of small, free cobalt cluster ions Co+n with n ≤ 9. J. Phys. Condens. Matter 2018, 30, 464002. [CrossRef]
268. Bucher, J.P.; Douglass, D.C.; Bloomfield, L.A. Magnetic properties of free cobalt clusters. Phys. Rev. Lett. 1991, 66, 3052–3055.
[CrossRef]
269. Jensen, P.J.; Bennemann, K.H. Magnetic properties of free ferromagnetic clusters in a Stern-Gerlach magnet. Comput. Mater. Sci.
1994, 2, 488–490. [CrossRef]
270. Knickelbein, M.B. Magnetic moments of bare and benzene-capped cobalt clusters. J. Chem. Phys. 2006, 125, 044308. [CrossRef]
271. Xu, X.; Yin, S.; Moro, R.; de Heer, W.A. Magnetic Moments and Adiabatic Magnetization of Free Cobalt Clusters. Phys. Rev. Lett.
2005, 95, 237209. [CrossRef]
272. Nealon, G.L.; Donnio, B.; Greget, R.; Kappler, J.P.; Terazzi, E.; Gallani, J.L. Magnetism in gold nanoparticles. Nanoscale 2012, 4,
5244–5258. [CrossRef]
273. Swart, I.; De Groot, F.M.F.; Weckhuysen, B.M.; Gruene, P.; Meijer, G.; Fielicke, A. H2 adsorption on 3d transition metal clusters:
A combined infrared spectroscopy and density functional study. J. Phys. Chem. A 2008, 112, 1139–1149. [CrossRef] [PubMed]
274. Sauer, J. Molecular Models in ab Initio Studies of Solids and Surfaces: From Ionic Crystals and Semiconductors to Catalysts.
Chem. Rev. 1989, 89, 199–255. [CrossRef]
275. Wang, G.C.; Jiang, L.; Morikawa, Y.; Nakamura, J.; Cai, Z.S.; Pan, Y.M.; Zhao, X.Z. Cluster and periodic DFT calculations of
adsorption and activation of CO2 on the Cu(hkl) surfaces. Surf. Sci. 2004, 570, 205–217. [CrossRef]
276. Pessoa, A.M.; Fajín, J.L.C.; Gomes, J.R.B.; Cordeiro, M.N.D.S. Cluster and periodic DFT calculations of adsorption of hydroxyl on
the Au(h k l) surfaces. J. Mol. Struct. THEOCHEM 2010, 946, 43–50. [CrossRef]
277. Psofogiannakis, G.; St-Amant, A.; Ternan, M. Methane oxidation mechanism on Pt(111): A cluster model DFT study. J. Phys.
Chem. B 2006, 110, 24593–24605. [CrossRef]
278. Zhenming, H.; Boyd, R.J. Structure sensitivity and cluster size convergence for formate adsorption on copper surfaces: A DFT
cluster model study. J. Chem. Phys. 2000, 112, 9562–9568. [CrossRef]
Materials 2021, 14, 3611 45 of 50
279. Dehmani, Y.; Lgaz, H.; Alrashdi, A.A.; Lamhasni, T.; Abouarnadasse, S.; Chung, I.M. Phenol adsorption mechanism on the
zinc oxide surface: Experimental, cluster DFT calculations, and molecular dynamics simulations. J. Mol. Liq. 2021, 324, 114993.
[CrossRef]
280. Tafreshi, S.S.; Roldan, A.; De Leeuw, N.H. Density Functional Theory Study of the Adsorption of Hydrazine on the Perfect and
Defective Copper (100), (110), and (111) Surfaces. J. Phys. Chem. C 2014, 118, 26103–26114. [CrossRef]
281. Liu, L.; Yu, M.; Hou, B.; Wang, Q.; Zhu, B.; Jia, L.; Li, D. Morphology evolution of fcc Ru nanoparticles under hydrogen
atmosphere. Nanoscale 2019, 11, 8037–8046. [CrossRef]
282. Zhao, P.; Cao, Z.; Liu, X.; Ren, P.; Cao, D.B.; Xiang, H.; Jiao, H.; Yang, Y.; Li, Y.W.; Wen, X.D. Morphology and Reactivity Evolution
of HCP and FCC Ru Nanoparticles under CO Atmosphere. ACS Catal. 2019, 9, 2768–2776. [CrossRef]
283. Shi, Q.; Sun, R. Adsorption manners of hydrogen on Pt(100), (110) and (111) surfaces at high coverage. Comput. Theor. Chem. 2017,
1106, 43–49. [CrossRef]
284. Avanesian, T.; Dai, S.; Kale, M.J.; Graham, G.W.; Pan, X.; Christopher, P. Quantitative and Atomic-Scale View of CO-Induced
Pt Nanoparticle Surface Reconstruction at Saturation Coverage via DFT Calculations Coupled with in Situ TEM and IR. J. Am.
Chem. Soc. 2017, 139, 4551–4558. [CrossRef] [PubMed]
285. Soon, A.; Wong, L.; Delley, B.; Stampfl, C. Morphology of copper nanoparticles in a nitrogen atmosphere: A first-principles
investigation. Phys. Rev. B Condens. Matter Mater. Phys. 2008, 77, 125423. [CrossRef]
286. Deshlahra, P.; Conway, J.; Wolf, E.E.; Schneider, W.F. Influence of Dipole–Dipole Interactions on Coverage-Dependent Adsorption:
CO and NO on Pt(111). Langmuir 2012, 28, 8408–8417. [CrossRef] [PubMed]
287. Bessarab, P.F.; Uzdin, V.M.; Jónsson, H. Effect of hydrogen adsorption on the magnetic properties of a surface nanocluster of iron.
Phys. Rev. B Condens. Matter Mater. Phys. 2013, 88, 14–16. [CrossRef]
288. Ram, S.; Lee, S.C.; Bhattacharjee, S. Adsorption energy scaling relation on bimetallic magnetic surfaces: Role of surface magnetic
moments. Phys. Chem. Chem. Phys. 2020, 22, 17960–17968. [CrossRef]
289. Pignocco, A.J.; Pellissier, G.E. Leed studies of oxygen adsorption and oxide formation on an (011) iron surface. Surf. Sci. 1967, 7,
261–278. [CrossRef]
290. Brundle, C.R. Oxygen adsorption and thin oxide formation at iron surfaces: An XPS/UPS study. Surf. Sci. 1977, 66, 581–595.
[CrossRef]
291. Holloway, P.H. Chemisorption and Oxide Formation on Metals: Oxygen-Nickel Reaction. J. Vac. Sci. Technol. 1980, 18, 653–659.
[CrossRef]
292. Li, W.X.; Stampfl, C.; Scheffler, M. Subsurface oxygen and surface oxide formation at Ag(111): A density-functional theory
investigation. Phys. Rev. B Condens. Matter Mater. Phys. 2003, 67, 045408. [CrossRef]
293. Todorova, M.; Reuter, K.; Scheffler, M. Oxygen overlayers on Pd(111) studied by density functional theory. J. Phys. Chem. B 2004,
108, 14477–14483. [CrossRef]
294. Shi, H.; Stampfl, C. First-principles investigations of the structure and stability of oxygen adsorption and surface oxide formation
at Au(111). Phys. Rev. B 2007, 76, 075327. [CrossRef]
295. Bridge, M.E.; Lambert, R.M. Oxygen chemisorption, surface oxidation, and the oxidation of carbon monoxide on cobalt (0001).
Surf. Sci. 1979, 82, 413–424. [CrossRef]
296. Farkaš, B.; Santos-Carballal, D.; Cadi-Essadek, A.; de Leeuw, N.H. A DFT+U study of the oxidation of cobalt nanoparticles:
Implications for biomedical applications. Materialia 2019, 7, 100381. [CrossRef]
297. Wang, L.; Maxisch, T.; Ceder, G. Oxidation energies of transition metal oxides within the GGA+U framework. Phys. Rev. B
Condens. Matter Mater. Phys. 2006, 73, 195107. [CrossRef]
298. Toroker, M.C.; Kanan, D.K.; Alidoust, N.; Isseroff, L.Y.; Liao, P.; Carter, E.A. First principles scheme to evaluate band edge
positions in potential transition metal oxide photocatalysts and photoelectrodes. Phys. Chem. Chem. Phys. 2011, 13, 16644–16654.
[CrossRef]
299. Getsoian, A.B.; Bell, A.T. The influence of functionals on density functional theory calculations of the properties of reducible
transition metal oxide catalysts. J. Phys. Chem. C 2013, 117, 25562–25578. [CrossRef]
300. Roth, W.L. Magnetic structures of MnO, FeO, CoO, and NiO. Phys. Rev. 1958, 110, 1333–1341. [CrossRef]
301. Wdowik, U.D.; Parlinski, K. Lattice dynamics of CoO from first principles. Phys. Rev. B Condens. Matter Mater. Phys. 2007,
75, 104306. [CrossRef]
302. Roth, W.L. The magnetic structure of Co3O4. J. Phys. Chem. Solids 1964, 25, 1–10. [CrossRef]
303. Scheerlinck, D.; Hautecler, S. Magnetic Interactions in Co3O4. Phys. Status Solidi 1976, 73, 223–228. [CrossRef]
304. Lee, B.; Ignatiev, A.; Taylor, J.; Rabalais, J. Atomic structure sensitivity of XPS: The oxidation of cobalt. Solid State Commun. 1980,
33, 1205–1208. [CrossRef]
305. Klingenberg, B.; Grellner, F.; Borgmann, D.; Wedler, G. Oxygen adsorption and oxide formation on Co(1120). Surf. Sci. 1993, 296,
374–382. [CrossRef]
306. Van Vleck, J.H. On the anisotropy of cubic ferromagnetic crystals. Phys. Rev. 1937, 52, 1178–1198. [CrossRef]
307. Brooks, H. Ferromagnetic Anisotropy and the Itinerant Electron Model. Phys. Rev. 1940, 58, 909–918. [CrossRef]
308. Fletcher, G.C. Calculations of the first ferromagnetic anisotropy coefficient, gyromagnetic ratio and spectroscopic splitting factor
for nickel. Proc. Phys. Soc. Sect. A 1954, 67, 505–519. [CrossRef]
Materials 2021, 14, 3611 46 of 50
309. Daalderop, G.H.O.; Kelly, P.J.; Schuurmans, M.F.H. First-principles calculation of the magnetic anisotropy energy of (Co)n/(X)m
multilayers. Phys. Rev. B 1990, 42, 7270–7273. [CrossRef]
310. Daalderop, G.H.O.; Kelly, P.J.; Den Broeder, F.J.A. Prediction and confirmation of perpendicular magnetic anisotropy in Co/Ni
multilayers. Phys. Rev. Lett. 1992, 68, 682–685. [CrossRef]
311. Berger, A.; Hopster, H. Nonequilibrium Magnetization near the Reorientation Phase Transition of Fe/Ag(100) Films.
Phys. Rev. Lett. 1996, 76, 519–522. [CrossRef]
312. Pütter, S.; Millev, Y.T.; Ding, H.F.; Kirschner, J.; Oepen, H.P. Magnetic susceptibility: An easy approach to the spin-reorientation
transition. Phys. Rev. B Condens. Matter Mater. Phys. 2001, 64, 092409. [CrossRef]
313. O’Brien, W.; Droubay, T.; Tonner, B. Transitions in the direction of magnetism in Ni/Cu(001) ultrathin films and the effects of
capping layers. Phys. Rev. B Condens. Matter Mater. Phys. 1996, 54, 9297–9303. [CrossRef]
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